ONTOLOGY REPORT - ANNOTATIONS
| Term: | indole-3-methanol |
|
| Accession: | CHEBI:24814
|
browse the term
|
| Definition: | An indolyl alcohol that has formula C9H9NO. |
| Synonyms: | exact_synonym: | 1H-indol-3-ylmethanol |
| | related_synonym: | 3-hydroxymethylindole; 3-indolylcarbinol; C9H9NO; InChI=1S/C9H9NO/c11-6-7-5-10-9-4-2-1-3-8(7)9/h1-5,10-11H,6H2; InChIKey=IVYPNXXAYMYVSP-UHFFFAOYSA-N; OCc1c[nH]c2ccccc12; indole-3-carbinol |
| | xref_casrn: | 700-06-1 |
| | xref: | Beilstein:121323 "Beilstein Registry Number"; ChEMBL:353232 "ChEMBL COMPOUND"; ChemIDplus:700-06-1 "CAS Registry Number"; Gmelin:1603301 "Gmelin Registry Number" |
| | xref_mesh: | MESH:C016517 |
|
|
indole-3-methanol
|
| G |
A2m |
alpha-2-macroglobulin |
|
affects expression |
EXP |
4 |
158,103,711 |
158,153,423 |
RGD:6480464 |
CTD |
| G |
Aamdc |
adipogenesis associated, Mth938 domain containing |
|
affects expression |
EXP |
1 |
154,786,525 |
154,817,248 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
decreases expression |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
|
affects expression |
EXP |
4 |
21,829,489 |
21,912,239 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
increases expression |
EXP |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
affects expression |
EXP |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
affects expression |
EXP |
10 |
82,986,552 |
83,030,799 |
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
multiple interactions |
EXP |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
affects expression |
EXP |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Abcd2 |
ATP-binding cassette, subfamily D (ALD), member 2 |
|
affects expression |
EXP |
7 |
129,542,758 |
129,591,363 |
RGD:6480464 |
CTD |
| G |
Abcd3 |
ATP-binding cassette, subfamily D (ALD), member 3 |
|
affects expression |
EXP |
2 |
218,396,071 |
218,432,172 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
increases expression |
ISO |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Abcg3l1 |
ATP-binding cassette, subfamily G (WHITE), member 3-like 1 |
|
affects expression |
EXP |
14 |
6,235,274 |
6,289,605 |
RGD:6480464 |
CTD |
| G |
Abcg3l3 |
ATP-binding cassette, subfamily G (WHITE), member 3-like 3 |
|
affects expression |
EXP |
14 |
5,950,942 |
5,998,413 |
RGD:6480464 |
CTD |
| G |
Abcg3l4 |
ATP-binding cassette, subfamily G (WHITE), member 3-like 4 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcg5 |
ATP-binding cassette, subfamily G (WHITE), member 5 |
|
affects expression |
EXP |
6 |
8,027,647 |
8,064,425 |
RGD:6480464 |
CTD |
| G |
Abcg8 |
ATP-binding cassette, subfamily G (WHITE), member 8 |
|
affects expression |
EXP |
6 |
8,064,631 |
8,083,271 |
RGD:6480464 |
CTD |
| G |
Abhd2 |
abhydrolase domain containing 2 |
|
affects expression |
EXP |
1 |
135,025,144 |
135,111,792 |
RGD:6480464 |
CTD |
| G |
Acer2 |
alkaline ceramidase 2 |
|
affects expression |
EXP |
5 |
106,185,779 |
106,237,588 |
RGD:6480464 |
CTD |
| G |
Acot3 |
acyl-CoA thioesterase 3 |
|
affects expression |
EXP |
6 |
108,089,349 |
108,095,288 |
RGD:6480464 |
CTD |
| G |
Acot5 |
acyl-CoA thioesterase 5 |
|
affects expression |
EXP |
6 |
108,114,686 |
108,122,769 |
RGD:6480464 |
CTD |
| G |
Acot8 |
acyl-CoA thioesterase 8 |
|
affects expression |
EXP |
3 |
155,828,209 |
155,839,862 |
RGD:6480464 |
CTD |
| G |
Acpp |
acid phosphatase, prostate |
|
affects expression |
EXP |
8 |
109,354,381 |
109,400,296 |
RGD:6480464 |
CTD |
| G |
Acsl3 |
acyl-CoA synthetase long-chain family member 3 |
|
affects expression |
EXP |
9 |
78,083,239 |
78,106,933 |
RGD:6480464 |
CTD |
| G |
Acsm3 |
acyl-CoA synthetase medium-chain family member 3 |
|
affects expression |
EXP |
1 |
178,054,386 |
178,081,751 |
RGD:6480464 |
CTD |
| G |
Acyp1 |
acylphosphatase 1, erythrocyte (common) type |
|
affects expression |
EXP |
6 |
109,320,444 |
109,327,303 |
RGD:6480464 |
CTD |
| G |
Adamtsl4 |
ADAMTS-like 4 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Adat2 |
adenosine deaminase, tRNA-specific 2 |
|
affects expression |
EXP |
1 |
8,358,164 |
8,372,650 |
RGD:6480464 |
CTD |
| G |
Adcy10 |
adenylate cyclase 10 (soluble) |
|
affects expression |
EXP |
13 |
81,208,090 |
81,302,902 |
RGD:6480464 |
CTD |
| G |
Adora1 |
adenosine A1 receptor |
|
affects expression |
EXP |
13 |
47,160,292 |
47,192,804 |
RGD:6480464 |
CTD |
| G |
Aebp1 |
AE binding protein 1 |
|
affects expression |
EXP |
14 |
86,525,748 |
86,535,664 |
RGD:6480464 |
CTD |
| G |
Agtr1a |
angiotensin II receptor, type 1a |
|
affects expression |
EXP |
17 |
40,629,318 |
40,684,982 |
RGD:6480464 |
CTD |
| G |
Ahi1 |
Abelson helper integration site 1 |
|
affects expression |
EXP |
1 |
16,332,801 |
16,454,055 |
RGD:6480464 |
CTD |
| G |
Ahnak |
AHNAK nucleoprotein |
|
affects expression |
EXP |
1 |
211,662,523 |
211,692,558 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
increases expression |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
affects expression |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Akap5 |
A kinase (PRKA) anchor protein 5 |
|
affects expression |
EXP |
6 |
98,923,105 |
98,928,505 |
RGD:6480464 |
CTD |
| G |
Akip1 |
A kinase (PRKA) interacting protein 1 |
|
affects expression |
EXP |
1 |
167,324,919 |
167,333,739 |
RGD:6480464 |
CTD |
| G |
Akirin1 |
akirin 1 |
|
affects expression |
EXP |
5 |
143,033,198 |
143,048,890 |
RGD:6480464 |
CTD |
| G |
Akr1b8 |
aldo-keto reductase family 1, member B8 |
|
affects expression |
EXP |
4 |
61,714,282 |
61,726,856 |
RGD:6480464 |
CTD |
| G |
Akr1c19 |
aldo-keto reductase family 1, member C19 |
|
affects expression |
EXP |
17 |
77,162,221 |
77,183,258 |
RGD:6480464 |
CTD |
| G |
Akr7a2 |
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) |
|
increases expression |
EXP |
5 |
158,097,679 |
158,106,217 |
RGD:6480464 |
CTD |
| G |
Alas2 |
aminolevulinate, delta-, synthase 2 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
increases expression |
ISO |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
affects expression |
EXP |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Aldh1a2 |
aldehyde dehydrogenase 1 family, member A2 |
|
decreases expression |
ISO |
8 |
75,692,099 |
75,771,159 |
RGD:6480464 |
CTD |
| G |
Aldh1a2 |
aldehyde dehydrogenase 1 family, member A2 |
|
multiple interactions |
ISO |
8 |
75,692,099 |
75,771,159 |
RGD:6480464 |
CTD |
| G |
Aldh3a1 |
aldehyde dehydrogenase 3 family, member A1 |
|
affects expression |
EXP |
10 |
47,365,195 |
47,374,880 |
RGD:6480464 |
CTD |
| G |
Alox15 |
arachidonate 15-lipoxygenase |
|
affects expression |
EXP |
10 |
57,185,939 |
57,194,388 |
RGD:6480464 |
CTD |
| G |
Alpk1 |
alpha-kinase 1 |
|
affects expression |
EXP |
2 |
224,934,194 |
224,989,819 |
RGD:6480464 |
CTD |
| G |
Amdhd1 |
amidohydrolase domain containing 1 |
|
affects expression |
EXP |
7 |
30,557,367 |
30,572,599 |
RGD:6480464 |
CTD |
| G |
Amdhd2 |
amidohydrolase domain containing 2 |
|
affects expression |
EXP |
10 |
13,407,051 |
13,415,537 |
RGD:6480464 |
CTD |
| G |
Amfr |
autocrine motility factor receptor, E3 ubiquitin protein ligase |
|
affects expression |
EXP |
19 |
11,434,553 |
11,467,592 |
RGD:6480464 |
CTD |
| G |
Anapc10 |
anaphase promoting complex subunit 10 |
|
affects expression |
EXP |
19 |
30,041,566 |
30,093,688 |
RGD:6480464 |
CTD |
| G |
Ankrd22 |
ankyrin repeat domain 22 |
|
affects expression |
EXP |
1 |
237,986,215 |
238,017,941 |
RGD:6480464 |
CTD |
| G |
Ankrd29 |
ankyrin repeat domain 29 |
|
affects expression |
EXP |
18 |
3,791,224 |
3,846,087 |
RGD:6480464 |
CTD |
| G |
Ankrd37 |
ankyrin repeat domain 37 |
|
affects expression |
EXP |
16 |
49,549,527 |
49,552,416 |
RGD:6480464 |
CTD |
| G |
Ankrd42 |
ankyrin repeat domain 42 |
|
affects expression |
EXP |
1 |
149,425,862 |
149,468,863 |
RGD:6480464 |
CTD |
| G |
Ankrd65 |
ankyrin repeat domain 65 |
|
affects expression |
EXP |
5 |
172,647,310 |
172,649,577 |
RGD:6480464 |
CTD |
| G |
Anp32e |
acidic (leucine-rich) nuclear phosphoprotein 32 family, member E |
|
affects expression |
EXP |
2 |
190,715,685 |
190,730,204 |
RGD:6480464 |
CTD |
| G |
Anxa5 |
annexin A5 |
|
affects expression |
EXP |
2 |
122,949,210 |
122,979,757 |
RGD:6480464 |
CTD |
| G |
Anxa7 |
annexin A7 |
|
affects expression |
EXP |
15 |
4,047,956 |
4,075,981 |
RGD:6480464 |
CTD |
| G |
Aox3 |
aldehyde oxidase 3 |
|
affects expression |
EXP |
9 |
56,779,880 |
56,867,683 |
RGD:6480464 |
CTD |
| G |
Aox4 |
aldehyde oxidase 4 |
|
affects expression |
EXP |
9 |
56,879,059 |
56,938,624 |
RGD:6480464 |
CTD |
| G |
Apbb1 |
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) |
|
affects expression |
EXP |
1 |
163,282,918 |
163,299,333 |
RGD:6480464 |
CTD |
| G |
Apeg3 |
antisense paternally expressed gene 3 |
|
affects expression |
EXP |
1 |
65,525,188 |
65,540,155 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
affects expression |
EXP |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
Aqp1 |
aquaporin 1 |
|
affects expression |
EXP |
4 |
84,098,346 |
84,110,524 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
decreases activity |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Arhgef9 |
Cdc42 guanine nucleotide exchange factor (GEF) 9 |
|
affects expression |
EXP |
X |
82,594,347 |
82,754,179 |
RGD:6480464 |
CTD |
| G |
Arl4a |
ADP-ribosylation factor-like 4A |
|
affects expression |
EXP |
6 |
59,212,599 |
59,214,609 |
RGD:6480464 |
CTD |
| G |
Arl6 |
ADP-ribosylation factor-like 6 |
|
affects expression |
EXP |
11 |
41,473,928 |
41,494,632 |
RGD:6480464 |
CTD |
| G |
Armcx1 |
armadillo repeat containing, X-linked 1 |
|
affects expression |
EXP |
X |
122,176,588 |
122,180,486 |
RGD:6480464 |
CTD |
| G |
Armcx3 |
armadillo repeat containing, X-linked 3 |
|
affects expression |
EXP |
X |
122,217,524 |
122,221,077 |
RGD:6480464 |
CTD |
| G |
Arpp21 |
cAMP-regulated phosphoprotein 21 |
|
affects expression |
EXP |
8 |
116,674,803 |
116,794,799 |
RGD:6480464 |
CTD |
| G |
Arv1 |
ARV1 homolog (S. cerevisiae) |
|
affects expression |
EXP |
19 |
54,904,721 |
54,916,541 |
RGD:6480464 |
CTD |
| G |
Asap2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
|
affects expression |
EXP |
6 |
41,664,580 |
41,828,032 |
RGD:6480464 |
CTD |
| G |
Asb5 |
ankyrin repeat and SOCS box-containing 5 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
|
affects expression |
EXP |
4 |
32,758,866 |
32,776,220 |
RGD:6480464 |
CTD |
| G |
Aspg |
asparaginase homolog (S. cerevisiae) |
|
affects expression |
EXP |
6 |
136,909,407 |
136,928,801 |
RGD:6480464 |
CTD |
| G |
Astl |
astacin-like metalloendopeptidase (M12 family) |
|
affects expression |
EXP |
3 |
114,845,320 |
114,861,053 |
RGD:6480464 |
CTD |
| G |
Atad2 |
ATPase family, AAA domain containing 2 |
|
affects expression |
EXP |
7 |
94,808,296 |
94,851,986 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
affects expression |
EXP |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Atp2b2 |
ATPase, Ca++ transporting, plasma membrane 2 |
|
affects expression |
EXP |
4 |
149,655,651 |
149,907,813 |
RGD:6480464 |
CTD |
| G |
Atp5g3 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9) |
|
affects expression |
EXP |
3 |
56,511,747 |
56,514,204 |
RGD:6480464 |
CTD |
| G |
Atp5s |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit s (factor B) |
|
affects expression |
EXP |
6 |
91,771,989 |
91,799,619 |
RGD:6480464 |
CTD |
| G |
Atp6ap1l |
ATPase, H+ transporting, lysosomal accessory protein 1-like |
|
affects expression |
EXP |
2 |
21,004,512 |
21,032,007 |
RGD:6480464 |
CTD |
| G |
Atp6v1c2 |
ATPase, H+ transporting, lysosomal V1 subunit C2 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Atpaf1 |
ATP synthase mitochondrial F1 complex assembly factor 1 |
|
affects expression |
EXP |
5 |
136,049,177 |
136,075,532 |
RGD:6480464 |
CTD |
| G |
Atpif1 |
ATPase inhibitory factor 1 |
|
affects expression |
EXP |
5 |
152,618,307 |
152,622,024 |
RGD:6480464 |
CTD |
| G |
Atrnl1 |
attractin like 1 |
|
affects expression |
EXP |
1 |
263,919,358 |
264,486,579 |
RGD:6480464 |
CTD |
| G |
Avpr1a |
arginine vasopressin receptor 1A |
|
affects expression |
EXP |
7 |
62,225,537 |
62,229,461 |
RGD:6480464 |
CTD |
| G |
B3gnt2 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 |
|
affects expression |
EXP |
14 |
103,499,471 |
103,524,296 |
RGD:6480464 |
CTD |
| G |
B9d1 |
B9 protein domain 1 |
|
affects expression |
EXP |
10 |
47,665,630 |
47,673,227 |
RGD:6480464 |
CTD |
| G |
Bahd1 |
bromo adjacent homology domain containing 1 |
|
affects expression |
EXP |
3 |
105,429,028 |
105,437,536 |
RGD:6480464 |
CTD |
| G |
Bai1 |
brain-specific angiogenesis inhibitor 1 |
|
affects expression |
EXP |
7 |
112,622,235 |
112,682,897 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2a1 |
BCL2-related protein A1 |
|
multiple interactions |
ISO |
8 |
94,045,109 |
94,053,777 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
decreases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Birc2 |
baculoviral IAP repeat-containing 2 |
|
multiple interactions |
ISO |
8 |
4,649,559 |
4,667,733 |
RGD:6480464 |
CTD |
| G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
multiple interactions |
ISO |
8 |
4,682,202 |
4,696,856 |
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Brca1 |
breast cancer 1, early onset |
|
multiple interactions |
ISO |
10 |
90,513,630 |
90,572,676 |
RGD:6480464 |
CTD |
| G |
Brca1 |
breast cancer 1, early onset |
|
multiple interactions |
ISO |
10 |
90,513,630 |
90,572,676 |
RGD:6480464 |
CTD |
| G |
Brca1 |
breast cancer 1, early onset |
|
multiple interactions |
ISO |
10 |
90,513,630 |
90,572,676 |
RGD:6480464 |
CTD |
| G |
Brca1 |
breast cancer 1, early onset |
|
increases expression |
ISO |
10 |
90,513,630 |
90,572,676 |
RGD:6480464 |
CTD |
| G |
Brca1 |
breast cancer 1, early onset |
|
increases expression |
ISO |
10 |
90,513,630 |
90,572,676 |
RGD:6480464 |
CTD |
| G |
Brca1 |
breast cancer 1, early onset |
|
increases expression |
ISO |
10 |
90,513,630 |
90,572,676 |
RGD:6480464 |
CTD |
| G |
Brca2 |
breast cancer 2, early onset |
|
increases expression |
ISO |
12 |
4,282,952 |
4,323,693 |
RGD:6480464 |
CTD |
| G |
Brca2 |
breast cancer 2, early onset |
|
multiple interactions |
ISO |
12 |
4,282,952 |
4,323,693 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases activity |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Ccdc176 |
coiled-coil domain containing 176 |
|
affects expression |
EXP |
6 |
108,473,030 |
108,498,836 |
RGD:6480464 |
CTD |
| G |
Ccdc178 |
coiled-coil domain containing 178 |
|
affects expression |
EXP |
18 |
13,440,195 |
13,817,915 |
RGD:6480464 |
CTD |
| G |
Ccdc41 |
coiled-coil domain containing 41 |
|
affects expression |
EXP |
7 |
31,911,351 |
31,984,394 |
RGD:6480464 |
CTD |
| G |
Ccdc71l |
coiled-coil domain containing 71-like |
|
affects expression |
EXP |
6 |
50,622,965 |
50,623,768 |
RGD:6480464 |
CTD |
| G |
Ccl4 |
chemokine (C-C motif) ligand 4 |
|
affects expression |
EXP |
10 |
71,759,643 |
71,761,115 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
affects expression |
EXP |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
affects expression |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd2 |
cyclin D2 |
|
affects expression |
EXP |
4 |
163,523,817 |
163,546,501 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
affects localization |
ISO |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
multiple interactions |
ISO |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
decreases expression |
ISO |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccnf |
cyclin F |
|
affects expression |
EXP |
10 |
13,474,659 |
13,500,979 |
RGD:6480464 |
CTD |
| G |
Cct5-ps2 |
chaperonin containing Tcp1, subunit 5 (epsilon), pseudogene 2 |
|
affects expression |
EXP |
8 |
17,626,188 |
17,626,589 |
RGD:6480464 |
CTD |
| G |
Cd14 |
CD14 molecule |
|
affects expression |
EXP |
18 |
29,374,593 |
29,376,190 |
RGD:6480464 |
CTD |
| G |
Cd207 |
CD207 molecule, langerin |
|
affects expression |
EXP |
4 |
117,866,542 |
117,872,334 |
RGD:6480464 |
CTD |
| G |
Cd24 |
CD24 molecule |
|
affects expression |
EXP |
20 |
47,502,354 |
47,507,663 |
RGD:6480464 |
CTD |
| G |
Cd38 |
CD38 molecule |
|
affects expression |
EXP |
14 |
72,320,479 |
72,360,329 |
RGD:6480464 |
CTD |
| G |
Cd40 |
CD40 molecule, TNF receptor superfamily member 5 |
|
multiple interactions |
ISO |
3 |
156,092,602 |
156,107,427 |
RGD:6480464 |
CTD |
| G |
Cd40 |
CD40 molecule, TNF receptor superfamily member 5 |
|
decreases expression |
ISO |
3 |
156,092,602 |
156,107,427 |
RGD:6480464 |
CTD |
| G |
Cd46 |
CD46 molecule, complement regulatory protein |
|
affects expression |
EXP |
13 |
110,972,812 |
111,003,407 |
RGD:6480464 |
CTD |
| G |
Cd80 |
Cd80 molecule |
|
increases expression |
ISO |
11 |
64,045,358 |
64,070,072 |
RGD:6480464 |
CTD |
| G |
Cd80 |
Cd80 molecule |
|
multiple interactions |
ISO |
11 |
64,045,358 |
64,070,072 |
RGD:6480464 |
CTD |
| G |
Cd84 |
CD84 molecule |
|
affects expression |
EXP |
13 |
87,846,411 |
87,859,987 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 molecule |
|
multiple interactions |
ISO |
11 |
66,215,233 |
66,238,882 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 molecule |
|
decreases expression |
ISO |
11 |
66,215,233 |
66,238,882 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 molecule |
|
increases expression |
ISO |
11 |
66,215,233 |
66,238,882 |
RGD:6480464 |
CTD |
| G |
Cd9 |
CD9 molecule |
|
affects expression |
EXP |
4 |
162,279,462 |
162,312,889 |
RGD:6480464 |
CTD |
| G |
Cdc25b |
cell division cycle 25B |
|
affects expression |
EXP |
3 |
118,893,716 |
118,903,516 |
RGD:6480464 |
CTD |
| G |
Cdh13 |
cadherin 13 |
|
affects expression |
EXP |
19 |
48,507,173 |
49,575,123 |
RGD:6480464 |
CTD |
| G |
Cdh17 |
cadherin 17 |
|
affects expression |
EXP |
5 |
26,047,222 |
26,099,173 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
affects localization |
ISO |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
multiple interactions |
ISO |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
decreases activity |
ISO |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
decreases activity |
ISO |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
decreases expression |
ISO |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
decreases activity |
ISO |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdk6 |
cyclin-dependent kinase 6 |
|
multiple interactions |
ISO |
4 |
27,362,656 |
27,618,006 |
RGD:6480464 |
CTD |
| G |
Cdk6 |
cyclin-dependent kinase 6 |
|
decreases activity |
ISO |
4 |
27,362,656 |
27,618,006 |
RGD:6480464 |
CTD |
| G |
Cdk6 |
cyclin-dependent kinase 6 |
|
decreases activity |
ISO |
4 |
27,362,656 |
27,618,006 |
RGD:6480464 |
CTD |
| G |
Cdk6 |
cyclin-dependent kinase 6 |
|
decreases expression |
ISO |
4 |
27,362,656 |
27,618,006 |
RGD:6480464 |
CTD |
| G |
Cdk6 |
cyclin-dependent kinase 6 |
|
decreases expression |
ISO |
4 |
27,362,656 |
27,618,006 |
RGD:6480464 |
CTD |
| G |
Cdk6 |
cyclin-dependent kinase 6 |
|
increases expression |
ISO |
4 |
27,362,656 |
27,618,006 |
RGD:6480464 |
CTD |
| G |
Cdk6 |
cyclin-dependent kinase 6 |
|
decreases expression |
ISO |
4 |
27,362,656 |
27,618,006 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
affects expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
increases expression |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
increases expression |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
increases expression |
ISO |
5 |
108,939,669 |
108,945,293 |
RGD:6480464 |
CTD |
| G |
Cds1 |
CDP-diacylglycerol synthase 1 |
|
affects expression |
EXP |
14 |
9,074,826 |
9,135,391 |
RGD:6480464 |
CTD |
| G |
Cdx1 |
caudal type homeo box 1 |
|
affects expression |
EXP |
18 |
56,983,284 |
57,006,721 |
RGD:6480464 |
CTD |
| G |
Ceacam10 |
carcinoembryonic antigen-related cell adhesion molecule 10 |
|
affects expression |
EXP |
1 |
80,070,252 |
80,076,528 |
RGD:6480464 |
CTD |
| G |
Ceacam20 |
carcinoembryonic antigen-related cell adhesion molecule 20 |
|
affects expression |
EXP |
1 |
79,275,467 |
79,297,252 |
RGD:6480464 |
CTD |
| G |
Cenpl |
centromere protein L |
|
affects expression |
EXP |
13 |
76,629,572 |
76,644,429 |
RGD:6480464 |
CTD |
| G |
Cers5 |
ceramide synthase 5 |
|
affects expression |
EXP |
7 |
138,475,151 |
138,513,647 |
RGD:6480464 |
CTD |
| G |
Ces2c |
carboxylesterase 2C |
|
affects expression |
EXP |
1 |
267,887,420 |
267,894,987 |
RGD:6480464 |
CTD |
| G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
|
multiple interactions |
ISO |
9 |
57,309,836 |
57,356,635 |
RGD:6480464 |
CTD |
| G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
|
decreases expression |
ISO |
9 |
57,309,836 |
57,356,635 |
RGD:6480464 |
CTD |
| G |
Chchd6 |
coiled-coil-helix-coiled-coil-helix domain containing 6 |
|
affects expression |
EXP |
4 |
123,458,141 |
123,681,700 |
RGD:6480464 |
CTD |
| G |
Chek1 |
checkpoint kinase 1 |
|
affects expression |
EXP |
8 |
37,954,322 |
37,974,748 |
RGD:6480464 |
CTD |
| G |
Chid1 |
chitinase domain containing 1 |
|
affects expression |
EXP |
1 |
201,683,719 |
201,718,785 |
RGD:6480464 |
CTD |
| G |
Chmp4bl1 |
chromatin modifying protein 4B-like 1 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Chmp4c |
charged multivesicular body protein 4C |
|
affects expression |
EXP |
2 |
93,330,478 |
93,382,152 |
RGD:6480464 |
CTD |
| G |
Chpf |
chondroitin polymerizing factor |
|
affects expression |
EXP |
9 |
74,749,945 |
74,754,639 |
RGD:6480464 |
CTD |
| G |
Chrac1 |
chromatin accessibility complex 1 |
|
affects expression |
EXP |
7 |
110,811,566 |
110,814,954 |
RGD:6480464 |
CTD |
| G |
Chrnb1 |
cholinergic receptor, nicotinic, beta 1 (muscle) |
|
affects expression |
EXP |
10 |
56,604,907 |
56,617,423 |
RGD:6480464 |
CTD |
| G |
Chuk |
conserved helix-loop-helix ubiquitous kinase |
|
multiple interactions |
ISO |
1 |
249,122,845 |
249,158,369 |
RGD:6480464 |
CTD |
| G |
Cidea |
cell death-inducing DFFA-like effector a |
|
affects expression |
EXP |
18 |
63,871,538 |
63,896,975 |
RGD:6480464 |
CTD |
| G |
Cirbp |
cold inducible RNA binding protein |
|
affects expression |
EXP |
7 |
11,047,003 |
11,050,820 |
RGD:6480464 |
CTD |
| G |
Clcc1 |
chloride channel CLIC-like 1 |
|
affects expression |
EXP |
2 |
204,245,357 |
204,278,530 |
RGD:6480464 |
CTD |
| G |
Cldn1 |
claudin 1 |
|
affects expression |
EXP |
11 |
76,473,654 |
76,488,809 |
RGD:6480464 |
CTD |
| G |
Clec10a |
C-type lectin domain family 10, member A |
|
affects expression |
EXP |
10 |
56,998,778 |
57,002,953 |
RGD:6480464 |
CTD |
| G |
Clybl |
citrate lyase beta like |
|
affects expression |
EXP |
15 |
107,313,924 |
107,539,458 |
RGD:6480464 |
CTD |
| G |
Col14a1 |
collagen, type XIV, alpha 1 |
|
affects expression |
EXP |
7 |
91,801,534 |
92,032,966 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
affects expression |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col4a3bp |
collagen, type IV, alpha 3 (Goodpasture antigen) binding protein |
|
affects expression |
EXP |
2 |
27,012,330 |
27,117,057 |
RGD:6480464 |
CTD |
| G |
Copg2 |
coatomer protein complex, subunit gamma 2 |
|
affects expression |
EXP |
4 |
57,859,156 |
57,958,208 |
RGD:6480464 |
CTD |
| G |
Coq10b |
coenzyme Q10 homolog B (S. cerevisiae) |
|
affects expression |
EXP |
9 |
53,858,750 |
53,878,664 |
RGD:6480464 |
CTD |
| G |
Cox6c-ps1 |
cytochrome c oxidase subunit VIc, pseudogene |
|
affects expression |
EXP |
19 |
54,397,944 |
54,398,802 |
RGD:6480464 |
CTD |
| G |
Cox8c |
cytochrome c oxidase, subunit VIIIc |
|
affects expression |
EXP |
6 |
127,161,354 |
127,162,677 |
RGD:6480464 |
CTD |
| G |
Cpeb2 |
cytoplasmic polyadenylation element binding protein 2 |
|
affects expression |
EXP |
14 |
72,955,778 |
73,007,518 |
RGD:6480464 |
CTD |
| G |
Cplx2 |
complexin 2 |
|
affects expression |
EXP |
17 |
16,314,592 |
16,322,938 |
RGD:6480464 |
CTD |
| G |
Cpz |
carboxypeptidase Z |
|
affects expression |
EXP |
14 |
80,857,371 |
80,880,592 |
RGD:6480464 |
CTD |
| G |
Crlf2 |
cytokine receptor-like factor 2 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cryab |
crystallin, alpha B |
|
affects expression |
EXP |
8 |
54,107,824 |
54,111,502 |
RGD:6480464 |
CTD |
| G |
Csmd1 |
CUB and Sushi multiple domains 1 |
|
affects expression |
EXP |
16 |
77,485,217 |
78,605,037 |
RGD:6480464 |
CTD |
| G |
Csrp1 |
cysteine and glycine-rich protein 1 |
|
affects expression |
EXP |
13 |
48,750,202 |
48,775,815 |
RGD:6480464 |
CTD |
| G |
Cstf3 |
cleavage stimulation factor, 3' pre-RNA, subunit 3, 77kDa |
|
affects expression |
EXP |
3 |
89,919,376 |
89,991,676 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
affects expression |
EXP |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctps |
CTP synthase |
|
affects expression |
EXP |
5 |
141,136,686 |
141,165,817 |
RGD:6480464 |
CTD |
| G |
Ctsd |
cathepsin D |
|
decreases expression |
ISO |
1 |
202,619,669 |
202,631,545 |
RGD:6480464 |
CTD |
| G |
Ctse |
cathepsin E |
|
affects expression |
EXP |
13 |
44,582,911 |
44,605,241 |
RGD:6480464 |
CTD |
| G |
Cxcl17 |
chemokine (C-X-C motif) ligand 17 |
|
affects expression |
EXP |
1 |
80,683,134 |
80,694,898 |
RGD:6480464 |
CTD |
| G |
Cxcl9 |
chemokine (C-X-C motif) ligand 9 |
|
affects expression |
EXP |
14 |
17,284,085 |
17,288,996 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
affects localization |
ISO |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cyhr1 |
cysteine/histidine-rich 1 |
|
affects expression |
EXP |
7 |
114,692,798 |
114,705,940 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases activity |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases activity |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
affects expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases activity |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases activity |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects expression |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
multiple interactions |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
affects expression |
EXP |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2b12 |
cytochrome P450, family 2, subfamily b, polypeptide 12 |
|
affects expression |
EXP |
1 |
81,780,088 |
81,791,887 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
EXP |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
affects expression |
EXP |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2c6v1 |
cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 |
|
affects expression |
EXP |
1 |
243,859,015 |
243,896,003 |
RGD:6480464 |
CTD |
| G |
Cyp2c6v2 |
cytochrome P450, family 2, subfamily c, polypeptide 6, variant 2 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2c80 |
cytochrome P450, family 2, subfamily c, polypeptide 80 |
|
affects expression |
EXP |
1 |
244,517,262 |
244,536,426 |
RGD:6480464 |
CTD |
| G |
Cyp2j10 |
cytochrome P450, family 2, subfamily j, polypeptide 10 |
|
affects expression |
EXP |
5 |
116,473,981 |
116,510,889 |
RGD:6480464 |
CTD |
| G |
Cyp3a62 |
cytochrome P450, family 3, subfamily a, polypeptide 62 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp3a85-ps |
cytochrome P450, family 3, subfamily a, polypeptide 85, pseudogene |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
|
affects expression |
EXP |
12 |
17,164,384 |
17,204,589 |
RGD:6480464 |
CTD |
| G |
Cyp4f17 |
cytochrome P450, family 4, subfamily f, polypeptide 17 |
|
affects expression |
EXP |
7 |
13,095,557 |
13,111,638 |
RGD:6480464 |
CTD |
| G |
Cyp7b1 |
cytochrome P450, family 7, subfamily b, polypeptide 1 |
|
affects expression |
EXP |
2 |
103,102,679 |
103,271,273 |
RGD:6480464 |
CTD |
| G |
Cyr61 |
cysteine-rich, angiogenic inducer, 61 |
|
affects expression |
EXP |
2 |
243,824,303 |
243,827,262 |
RGD:6480464 |
CTD |
| G |
Dab1 |
Dab, reelin signal transducer, homolog 1 (Drosophila) |
|
affects expression |
EXP |
5 |
125,434,133 |
125,694,562 |
RGD:6480464 |
CTD |
| G |
Dapp1 |
dual adaptor of phosphotyrosine and 3-phosphoinositides |
|
affects expression |
EXP |
2 |
235,423,487 |
235,474,068 |
RGD:6480464 |
CTD |
| G |
Dbn1 |
drebrin 1 |
|
affects expression |
EXP |
17 |
15,194,687 |
15,208,660 |
RGD:6480464 |
CTD |
| G |
Ddah2 |
dimethylarginine dimethylaminohydrolase 2 |
|
affects expression |
EXP |
20 |
3,829,767 |
3,836,141 |
RGD:6480464 |
CTD |
| G |
Ddc |
dopa decarboxylase (aromatic L-amino acid decarboxylase) |
|
affects expression |
EXP |
14 |
92,698,636 |
92,788,635 |
RGD:6480464 |
CTD |
| G |
Derl3 |
derlin 3 |
|
affects expression |
EXP |
20 |
13,163,287 |
13,165,848 |
RGD:6480464 |
CTD |
| G |
Dhrs7 |
dehydrogenase/reductase (SDR family) member 7 |
|
affects expression |
EXP |
6 |
95,005,675 |
95,029,519 |
RGD:6480464 |
CTD |
| G |
Dhx9 |
DEAH (Asp-Glu-Ala-His) box polypeptide 9 |
|
affects expression |
EXP |
13 |
68,471,256 |
68,507,999 |
RGD:6480464 |
CTD |
| G |
Diablo |
diablo, IAP-binding mitochondrial protein |
|
affects expression |
EXP |
12 |
34,196,347 |
34,209,633 |
RGD:6480464 |
CTD |
| G |
Dimt1 |
DIM1 dimethyladenosine transferase 1 homolog (S. cerevisiae) |
|
affects expression |
EXP |
2 |
38,054,640 |
38,078,326 |
RGD:6480464 |
CTD |
| G |
Dmbt1 |
deleted in malignant brain tumors 1 |
|
affects expression |
EXP |
1 |
190,378,428 |
190,470,536 |
RGD:6480464 |
CTD |
| G |
Dmxl2 |
Dmx-like 2 |
|
affects expression |
EXP |
8 |
57,857,243 |
58,047,495 |
RGD:6480464 |
CTD |
| G |
Dnaaf2 |
dynein, axonemal, assembly factor 2 |
|
affects expression |
EXP |
6 |
91,142,003 |
91,149,874 |
RGD:6480464 |
CTD |
| G |
Dnah3 |
dynein, axonemal, heavy chain 3 |
|
multiple interactions |
EXP |
1 |
178,234,649 |
178,311,979 |
RGD:6480464 |
CTD |
| G |
Dnajc18 |
DnaJ (Hsp40) homolog, subfamily C, member 18 |
|
affects expression |
EXP |
18 |
28,293,234 |
28,321,325 |
RGD:6480464 |
CTD |
| G |
Dnlz |
DNL-type zinc finger |
|
affects expression |
EXP |
3 |
4,522,915 |
4,524,662 |
RGD:6480464 |
CTD |
| G |
Dnmt3b |
DNA (cytosine-5-)-methyltransferase 3 beta |
|
affects expression |
EXP |
3 |
144,030,737 |
144,069,265 |
RGD:6480464 |
CTD |
| G |
Dpep1 |
dipeptidase 1 (renal) |
|
affects expression |
EXP |
19 |
53,503,467 |
53,518,440 |
RGD:6480464 |
CTD |
| G |
Dppa3-ps1 |
developmental pluripotency-associated 3, pseudogene 1 |
|
affects expression |
EXP |
3 |
105,984,535 |
105,985,011 |
RGD:6480464 |
CTD |
| G |
Dqx1 |
DEAQ box RNA-dependent ATPase 1 |
|
affects expression |
EXP |
4 |
117,269,044 |
117,277,882 |
RGD:6480464 |
CTD |
| G |
Drg1 |
developmentally regulated GTP binding protein 1 |
|
affects expression |
EXP |
14 |
83,855,894 |
83,871,922 |
RGD:6480464 |
CTD |
| G |
Dtx3 |
deltex homolog 3 (Drosophila) |
|
affects expression |
EXP |
7 |
67,145,276 |
67,149,937 |
RGD:6480464 |
CTD |
| G |
Dusp13 |
dual specificity phosphatase 13 |
|
affects expression |
EXP |
15 |
2,614,864 |
2,630,230 |
RGD:6480464 |
CTD |
| G |
Dusp19 |
dual specificity phosphatase 19 |
|
affects expression |
EXP |
3 |
63,473,333 |
63,485,843 |
RGD:6480464 |
CTD |
| G |
Dusp4 |
dual specificity phosphatase 4 |
|
affects expression |
EXP |
16 |
61,109,626 |
61,119,981 |
RGD:6480464 |
CTD |
| G |
Dusp8 |
dual specificity phosphatase 8 |
|
affects expression |
EXP |
1 |
202,215,086 |
202,229,746 |
RGD:6480464 |
CTD |
| G |
Dut |
deoxyuridine triphosphatase |
|
affects expression |
EXP |
3 |
112,551,434 |
112,562,434 |
RGD:6480464 |
CTD |
| G |
Efna5 |
ephrin A5 |
|
affects expression |
EXP |
9 |
101,227,615 |
101,532,696 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
decreases expression |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egln3 |
EGL nine homolog 3 (C. elegans) |
|
affects expression |
EXP |
6 |
74,451,038 |
74,476,506 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
affects expression |
EXP |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Eif2b2 |
eukaryotic translation initiation factor 2B, subunit 2 beta |
|
affects expression |
EXP |
6 |
109,266,354 |
109,272,778 |
RGD:6480464 |
CTD |
| G |
Eif5a2 |
eukaryotic translation initiation factor 5A2 |
|
affects expression |
EXP |
2 |
116,143,415 |
116,156,197 |
RGD:6480464 |
CTD |
| G |
Elavl4 |
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4 |
|
affects expression |
EXP |
5 |
131,672,012 |
131,767,950 |
RGD:6480464 |
CTD |
| G |
Emb |
embigin |
|
affects expression |
EXP |
2 |
49,098,743 |
49,155,221 |
RGD:6480464 |
CTD |
| G |
Eml5 |
echinoderm microtubule associated protein like 5 |
|
affects expression |
EXP |
6 |
122,958,412 |
123,087,547 |
RGD:6480464 |
CTD |
| G |
Emp3 |
epithelial membrane protein 3 |
|
affects expression |
EXP |
1 |
96,389,783 |
96,392,960 |
RGD:6480464 |
CTD |
| G |
Enc1 |
ectodermal-neural cortex 1 |
|
affects expression |
EXP |
2 |
27,720,805 |
27,733,168 |
RGD:6480464 |
CTD |
| G |
Enpep |
glutamyl aminopeptidase |
|
affects expression |
EXP |
2 |
226,731,079 |
226,732,069 |
RGD:6480464 |
CTD |
| G |
Entpd5 |
ectonucleoside triphosphate diphosphohydrolase 5 |
|
affects expression |
EXP |
6 |
108,439,822 |
108,469,756 |
RGD:6480464 |
CTD |
| G |
Epcam |
epithelial cell adhesion molecule |
|
affects expression |
EXP |
6 |
11,176,664 |
11,192,628 |
RGD:6480464 |
CTD |
| G |
Epha1 |
Eph receptor A1 |
|
affects expression |
EXP |
4 |
70,127,872 |
70,142,309 |
RGD:6480464 |
CTD |
| G |
Epha2 |
Eph receptor A2 |
|
affects expression |
EXP |
5 |
160,185,143 |
160,214,727 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
affects expression |
EXP |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
decreases expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Fcnb |
ficolin B |
|
affects expression |
EXP |
3 |
7,010,989 |
7,019,366 |
RGD:6480464 |
CTD |
| G |
Fdxacb1 |
ferredoxin-fold anticodon binding domain containing 1 |
|
affects expression |
EXP |
8 |
54,125,767 |
54,130,196 |
RGD:6480464 |
CTD |
| G |
Fgd1 |
FYVE, RhoGEF and PH domain containing 1 |
|
affects expression |
EXP |
X |
40,364,211 |
40,407,213 |
RGD:6480464 |
CTD |
| G |
Fgf1 |
fibroblast growth factor 1 (acidic) |
|
affects expression |
EXP |
18 |
31,785,480 |
31,806,452 |
RGD:6480464 |
CTD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
affects expression |
EXP |
2 |
123,893,314 |
123,947,136 |
RGD:6480464 |
CTD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
affects expression |
EXP |
1 |
189,482,975 |
189,589,279 |
RGD:6480464 |
CTD |
| G |
Fhit |
fragile histidine triad |
|
affects expression |
EXP |
15 |
15,823,461 |
17,329,184 |
RGD:6480464 |
CTD |
| G |
Fkbp11 |
FK506 binding protein 11 |
|
affects expression |
EXP |
7 |
137,490,985 |
137,494,418 |
RGD:6480464 |
CTD |
| G |
Fkbp3 |
FK506 binding protein 3 |
|
affects expression |
EXP |
6 |
86,410,859 |
86,422,588 |
RGD:6480464 |
CTD |
| G |
Foxd4 |
forkhead box D4 |
|
affects expression |
EXP |
1 |
228,348,202 |
228,349,654 |
RGD:6480464 |
CTD |
| G |
Fxc1-ps1 |
fractured callus expressed transcript 1, pseudogene 1 |
|
affects expression |
EXP |
20 |
47,476,666 |
47,476,965 |
RGD:6480464 |
CTD |
| G |
Fxyd2 |
FXYD domain-containing ion transport regulator 2 |
|
affects expression |
EXP |
8 |
48,379,075 |
48,385,553 |
RGD:6480464 |
CTD |
| G |
Fxyd3 |
FXYD domain-containing ion transport regulator 3 |
|
affects expression |
EXP |
1 |
86,113,706 |
86,120,488 |
RGD:6480464 |
CTD |
| G |
Fxyd6 |
FXYD domain-containing ion transport regulator 6 |
|
affects expression |
EXP |
8 |
48,323,818 |
48,371,958 |
RGD:6480464 |
CTD |
| G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
|
affects expression |
EXP |
7 |
10,289,073 |
10,291,102 |
RGD:6480464 |
CTD |
| G |
Galnt16 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 16 |
|
affects expression |
EXP |
6 |
104,285,081 |
104,366,257 |
RGD:6480464 |
CTD |
| G |
Gar1 |
GAR1 ribonucleoprotein homolog (yeast) |
|
affects expression |
EXP |
2 |
227,267,775 |
227,275,054 |
RGD:6480464 |
CTD |
| G |
Gcat |
glycine C-acetyltransferase |
|
affects expression |
EXP |
7 |
117,003,626 |
117,010,396 |
RGD:6480464 |
CTD |
| G |
Gcnt3 |
glucosaminyl (N-acetyl) transferase 3, mucin type |
|
affects expression |
EXP |
8 |
74,470,610 |
74,474,086 |
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
increases expression |
ISO |
16 |
19,310,882 |
19,313,465 |
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
multiple interactions |
ISO |
16 |
19,310,882 |
19,313,465 |
RGD:6480464 |
CTD |
| G |
Gfra3 |
GDNF family receptor alpha 3 |
|
affects expression |
EXP |
18 |
27,167,576 |
27,195,848 |
RGD:6480464 |
CTD |
| G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gins4 |
GINS complex subunit 4 (Sld5 homolog) |
|
affects expression |
EXP |
16 |
73,245,883 |
73,257,267 |
RGD:6480464 |
CTD |
| G |
Gipc2 |
GIPC PDZ domain containing family, member 2 |
|
affects expression |
EXP |
2 |
250,704,151 |
250,733,988 |
RGD:6480464 |
CTD |
| G |
Gldc |
glycine dehydrogenase (decarboxylating) |
|
affects expression |
EXP |
1 |
233,846,690 |
233,925,736 |
RGD:6480464 |
CTD |
| G |
Glmn |
glomulin, FKBP associated protein |
|
affects expression |
EXP |
14 |
2,744,359 |
2,789,190 |
RGD:6480464 |
CTD |
| G |
Glrx |
glutaredoxin (thioltransferase) |
|
affects expression |
EXP |
2 |
2,888,605 |
2,899,216 |
RGD:6480464 |
CTD |
| G |
Glt1d1 |
glycosyltransferase 1 domain containing 1 |
|
affects expression |
EXP |
12 |
30,026,320 |
30,098,182 |
RGD:6480464 |
CTD |
| G |
Gnai1 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
|
affects expression |
EXP |
4 |
12,465,089 |
12,495,028 |
RGD:6480464 |
CTD |
| G |
Gnptab |
N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits |
|
affects expression |
EXP |
7 |
25,084,137 |
25,149,880 |
RGD:6480464 |
CTD |
| G |
Gnrh1 |
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) |
|
affects expression |
EXP |
15 |
47,303,309 |
47,307,517 |
RGD:6480464 |
CTD |
| G |
Gp5 |
glycoprotein V (platelet) |
|
affects expression |
EXP |
11 |
72,341,773 |
72,344,865 |
RGD:6480464 |
CTD |
| G |
Gpa33 |
glycoprotein A33 (transmembrane) |
|
affects expression |
EXP |
13 |
81,858,333 |
81,892,579 |
RGD:6480464 |
CTD |
| G |
Gpatch4 |
G patch domain containing 4 |
|
affects expression |
EXP |
2 |
180,123,437 |
180,132,225 |
RGD:6480464 |
CTD |
| G |
Gpc3 |
glypican 3 |
|
affects expression |
EXP |
X |
139,192,115 |
139,560,649 |
RGD:6480464 |
CTD |
| G |
Gpr98 |
G protein-coupled receptor 98 |
|
affects expression |
EXP |
2 |
8,851,539 |
8,915,885 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
increases expression |
EXP |
6 |
99,372,418 |
99,376,230 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
affects expression |
EXP |
6 |
99,372,418 |
99,376,230 |
RGD:6480464 |
CTD |
| G |
Grifin |
galectin-related inter-fiber protein |
|
affects expression |
EXP |
12 |
14,547,385 |
14,549,367 |
RGD:6480464 |
CTD |
| G |
Grin2c |
glutamate receptor, ionotropic, N-methyl D-aspartate 2C |
|
affects expression |
EXP |
10 |
105,323,371 |
105,340,976 |
RGD:6480464 |
CTD |
| G |
Grk5 |
G protein-coupled receptor kinase 5 |
|
affects expression |
EXP |
1 |
267,495,534 |
267,693,144 |
RGD:6480464 |
CTD |
| G |
Gsn |
gelsolin |
|
affects expression |
EXP |
3 |
14,360,245 |
14,386,313 |
RGD:6480464 |
CTD |
| G |
Gsta1 |
glutathione S-transferase alpha 1 |
|
increases expression |
ISO |
9 |
20,051,501 |
20,068,146 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
multiple interactions |
EXP |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
increases expression |
ISO |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
increases expression |
EXP |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gsta3 |
glutathione S-transferase alpha 3 |
|
multiple interactions |
EXP |
9 |
20,005,570 |
20,032,031 |
RGD:6480464 |
CTD |
| G |
Gsta3 |
glutathione S-transferase alpha 3 |
|
increases expression |
ISO |
9 |
20,005,570 |
20,032,031 |
RGD:6480464 |
CTD |
| G |
Gsta3 |
glutathione S-transferase alpha 3 |
|
increases expression |
EXP |
9 |
20,005,570 |
20,032,031 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
increases expression |
ISO |
8 |
83,165,139 |
83,183,055 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
affects expression |
EXP |
8 |
83,165,139 |
83,183,055 |
RGD:6480464 |
CTD |
| G |
Gsta5 |
glutathione S-transferase alpha 5 |
|
increases activity |
EXP |
8 |
83,202,554 |
83,211,997 |
RGD:6480464 |
CTD |
| G |
Gsta5 |
glutathione S-transferase alpha 5 |
|
increases expression |
EXP |
8 |
83,202,554 |
83,211,997 |
RGD:6480464 |
CTD |
| G |
Gsta5 |
glutathione S-transferase alpha 5 |
|
increases expression |
EXP |
8 |
83,202,554 |
83,211,997 |
RGD:6480464 |
CTD |
| G |
Gsta5 |
glutathione S-transferase alpha 5 |
|
multiple interactions |
EXP |
8 |
83,202,554 |
83,211,997 |
RGD:6480464 |
CTD |
| G |
Gsta5 |
glutathione S-transferase alpha 5 |
|
affects expression |
EXP |
8 |
83,202,554 |
83,211,997 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
increases expression |
ISO |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm2 |
glutathione S-transferase mu 2 |
|
affects expression |
EXP |
2 |
203,549,022 |
203,553,380 |
RGD:6480464 |
CTD |
| G |
Gstm3 |
glutathione S-transferase mu 3 |
|
affects expression |
EXP |
2 |
203,532,363 |
203,537,135 |
RGD:6480464 |
CTD |
| G |
Gstm4 |
glutathione S-transferase mu 4 |
|
affects expression |
EXP |
2 |
203,605,593 |
203,610,817 |
RGD:6480464 |
CTD |
| G |
Gsto2 |
glutathione S-transferase omega 2 |
|
affects expression |
EXP |
1 |
253,239,392 |
253,275,110 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
affects expression |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
increases expression |
EXP |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
affects expression |
EXP |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gtf2h5 |
general transcription factor IIH, polypeptide 5 |
|
affects expression |
EXP |
1 |
40,858,997 |
40,865,571 |
RGD:6480464 |
CTD |
| G |
Gtpbp10 |
GTP-binding protein 10 (putative) |
|
affects expression |
EXP |
4 |
25,162,478 |
25,179,996 |
RGD:6480464 |
CTD |
| G |
Gtpbp8 |
GTP-binding protein 8 (putative) |
|
affects expression |
EXP |
11 |
57,484,578 |
57,494,406 |
RGD:6480464 |
CTD |
| G |
Gxylt1 |
glucoside xylosyltransferase 1 |
|
affects expression |
EXP |
7 |
131,726,969 |
131,761,134 |
RGD:6480464 |
CTD |
| G |
Hal |
histidine ammonia lyase |
|
affects expression |
EXP |
7 |
30,520,913 |
30,551,145 |
RGD:6480464 |
CTD |
| G |
Hamp |
hepcidin antimicrobial peptide |
|
affects expression |
EXP |
1 |
85,978,120 |
85,980,059 |
RGD:6480464 |
CTD |
| G |
Hao2 |
hydroxyacid oxidase 2 (long chain) |
|
affects expression |
EXP |
2 |
193,532,833 |
193,557,229 |
RGD:6480464 |
CTD |
| G |
Haus1 |
HAUS augmin-like complex, subunit 1 |
|
affects expression |
EXP |
18 |
74,718,279 |
74,729,487 |
RGD:6480464 |
CTD |
| G |
Hbb |
hemoglobin, beta |
|
affects expression |
EXP |
1 |
161,618,782 |
161,620,193 |
RGD:6480464 |
CTD |
| G |
Hbb-b1 |
hemoglobin, beta adult major chain |
|
affects expression |
EXP |
1 |
161,590,671 |
161,598,127 |
RGD:6480464 |
CTD |
| G |
Hdc |
histidine decarboxylase |
|
affects expression |
EXP |
3 |
114,119,316 |
114,138,107 |
RGD:6480464 |
CTD |
| G |
Hddc2 |
HD domain containing 2 |
|
affects expression |
EXP |
1 |
26,955,259 |
26,975,139 |
RGD:6480464 |
CTD |
| G |
Hebp2 |
heme binding protein 2 |
|
affects expression |
EXP |
1 |
13,628,658 |
13,635,958 |
RGD:6480464 |
CTD |
| G |
Hells |
helicase, lymphoid specific |
|
affects expression |
EXP |
1 |
243,246,843 |
243,262,459 |
RGD:6480464 |
CTD |
| G |
Hid1 |
HID1 domain containing |
|
affects expression |
EXP |
10 |
105,424,827 |
105,445,183 |
RGD:6480464 |
CTD |
| G |
Hira |
HIR histone cell cycle regulation defective homolog A (S. cerevisiae) |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Hist1h2ai |
histone cluster 1, H2ai |
|
affects expression |
EXP |
17 |
50,352,763 |
50,353,155 |
RGD:6480464 |
CTD |
| G |
Hist1h2ak |
histone cluster 1, H2ak |
|
affects expression |
EXP |
17 |
50,436,332 |
50,436,724 |
RGD:6480464 |
CTD |
| G |
Hlcs |
holocarboxylase synthetase (biotin-(proprionyl-CoA-carboxylase (ATP-hydrolysing)) ligase) |
|
affects expression |
EXP |
11 |
34,382,010 |
34,539,032 |
RGD:6480464 |
CTD |
| G |
Hmg20a |
high mobility group 20A |
|
affects expression |
EXP |
8 |
60,014,815 |
60,091,988 |
RGD:6480464 |
CTD |
| G |
Hmgb2 |
high mobility group box 2 |
|
affects expression |
EXP |
16 |
36,131,304 |
36,133,878 |
RGD:6480464 |
CTD |
| G |
Hmgn3 |
high mobility group nucleosome binding domain 3 |
|
affects expression |
EXP |
8 |
88,168,415 |
88,205,046 |
RGD:6480464 |
CTD |
| G |
Hoxc13 |
homeobox C13 |
|
affects expression |
EXP |
7 |
141,685,004 |
141,691,159 |
RGD:6480464 |
CTD |
| G |
Hpgds |
hematopoietic prostaglandin D synthase |
|
affects expression |
EXP |
4 |
94,611,607 |
94,636,147 |
RGD:6480464 |
CTD |
| G |
Hps3 |
Hermansky-Pudlak syndrome 3 homolog (human) |
|
affects expression |
EXP |
2 |
105,135,644 |
105,177,925 |
RGD:6480464 |
CTD |
| G |
Hpse |
heparanase |
|
affects expression |
EXP |
14 |
10,144,322 |
10,185,115 |
RGD:6480464 |
CTD |
| G |
Htatip2 |
HIV-1 Tat interactive protein 2 |
|
affects expression |
EXP |
1 |
99,563,187 |
99,577,802 |
RGD:6480464 |
CTD |
| G |
Ica1 |
islet cell autoantigen 1 |
|
affects expression |
EXP |
4 |
33,680,878 |
33,830,443 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
decreases expression |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Ido1 |
indoleamine 2,3-dioxygenase 1 |
|
increases expression |
ISO |
16 |
71,866,340 |
71,878,373 |
RGD:6480464 |
CTD |
| G |
Ido1 |
indoleamine 2,3-dioxygenase 1 |
|
multiple interactions |
ISO |
16 |
71,866,340 |
71,878,373 |
RGD:6480464 |
CTD |
| G |
Ido2 |
indoleamine 2,3-dioxygenase 2 |
|
increases expression |
ISO |
16 |
71,907,113 |
71,932,910 |
RGD:6480464 |
CTD |
| G |
Ido2 |
indoleamine 2,3-dioxygenase 2 |
|
multiple interactions |
ISO |
16 |
71,907,113 |
71,932,910 |
RGD:6480464 |
CTD |
| G |
Ifi204 |
interferon activated gene 204 |
|
affects expression |
EXP |
13 |
89,752,997 |
89,770,167 |
RGD:6480464 |
CTD |
| G |
Ifi47 |
interferon gamma inducible protein 47 |
|
affects expression |
EXP |
10 |
34,197,630 |
34,205,133 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
decreases secretion |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ift43 |
intraflagellar transport 43 homolog (Chlamydomonas) |
|
affects expression |
EXP |
6 |
110,199,027 |
110,276,696 |
RGD:6480464 |
CTD |
| G |
Ift74 |
intraflagellar transport 74 homolog (Chlamydomonas) |
|
affects expression |
EXP |
5 |
114,913,347 |
115,003,963 |
RGD:6480464 |
CTD |
| G |
Igfals |
insulin-like growth factor binding protein, acid labile subunit |
|
affects expression |
EXP |
10 |
14,127,416 |
14,130,662 |
RGD:6480464 |
CTD |
| G |
Igtp |
interferon gamma induced GTPase |
|
affects expression |
EXP |
10 |
43,829,273 |
43,837,092 |
RGD:6480464 |
CTD |
| G |
Ikbkb |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
|
multiple interactions |
ISO |
16 |
73,804,730 |
73,858,510 |
RGD:6480464 |
CTD |
| G |
Ikbke |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon |
|
affects expression |
EXP |
13 |
44,197,625 |
44,222,609 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
decreases secretion |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il12rb1 |
interleukin 12 receptor, beta 1 |
|
affects expression |
EXP |
16 |
19,126,653 |
19,137,584 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il27 |
interleukin 27 |
|
decreases expression |
ISO |
1 |
185,730,394 |
185,735,604 |
RGD:6480464 |
CTD |
| G |
Il27 |
interleukin 27 |
|
multiple interactions |
ISO |
1 |
185,730,394 |
185,735,604 |
RGD:6480464 |
CTD |
| G |
Il33 |
interleukin 33 |
|
affects expression |
EXP |
1 |
233,670,801 |
233,685,798 |
RGD:6480464 |
CTD |
| G |
Il36b |
interleukin 36, beta |
|
affects expression |
EXP |
3 |
2,510,815 |
2,515,661 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Inhbc |
inhibin beta C |
|
affects expression |
EXP |
7 |
67,315,295 |
67,328,764 |
RGD:6480464 |
CTD |
| G |
Ipo7 |
importin 7 |
|
affects expression |
EXP |
1 |
167,658,312 |
167,698,113 |
RGD:6480464 |
CTD |
| G |
Irgm |
immunity-related GTPase family, M |
|
affects expression |
EXP |
10 |
34,132,512 |
34,140,450 |
RGD:6480464 |
CTD |
| G |
Itgax |
integrin, alpha X |
|
multiple interactions |
ISO |
1 |
187,396,184 |
187,416,273 |
RGD:6480464 |
CTD |
| G |
Itgax |
integrin, alpha X |
|
decreases expression |
ISO |
1 |
187,396,184 |
187,416,273 |
RGD:6480464 |
CTD |
| G |
Itgb1bp2 |
integrin beta 1 binding protein 2 |
|
affects expression |
EXP |
X |
89,520,700 |
89,525,600 |
RGD:6480464 |
CTD |
| G |
Itgb3bp |
integrin beta 3 binding protein (beta3-endonexin) |
|
affects expression |
EXP |
5 |
120,459,569 |
120,525,476 |
RGD:6480464 |
CTD |
| G |
Itgb6 |
integrin, beta 6 |
|
affects expression |
EXP |
3 |
42,286,140 |
42,360,793 |
RGD:6480464 |
CTD |
| G |
Ka11 |
type I keratin KA11 |
|
affects expression |
EXP |
10 |
89,167,849 |
89,170,728 |
RGD:6480464 |
CTD |
| G |
Katnal2 |
katanin p60 subunit A-like 2 |
|
affects expression |
EXP |
18 |
73,955,032 |
73,998,321 |
RGD:6480464 |
CTD |
| G |
Kcnn2 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 |
|
affects expression |
EXP |
18 |
39,560,962 |
39,705,037 |
RGD:6480464 |
CTD |
| G |
Kcnq2 |
potassium voltage-gated channel, KQT-like subfamily, member 2 |
|
affects expression |
EXP |
3 |
170,227,938 |
170,282,887 |
RGD:6480464 |
CTD |
| G |
Kif14 |
kinesin family member 14 |
|
affects expression |
EXP |
13 |
49,514,095 |
49,576,012 |
RGD:6480464 |
CTD |
| G |
Kif1c |
kinesin family member 1C |
|
affects expression |
EXP |
10 |
57,580,646 |
57,622,517 |
RGD:6480464 |
CTD |
| G |
Kif20a |
kinesin family member 20A |
|
affects expression |
EXP |
18 |
27,100,044 |
27,108,530 |
RGD:6480464 |
CTD |
| G |
Kif3a |
kinesin family member 3a |
|
affects expression |
EXP |
10 |
39,029,351 |
39,062,570 |
RGD:6480464 |
CTD |
| G |
Kifc3 |
kinesin family member C3 |
|
affects expression |
EXP |
19 |
10,335,789 |
10,354,364 |
RGD:6480464 |
CTD |
| G |
Klf6 |
Kruppel-like factor 6 |
|
affects expression |
EXP |
17 |
75,578,498 |
75,585,072 |
RGD:6480464 |
CTD |
| G |
Klk7 |
kallikrein-related peptidase 7 |
|
affects expression |
EXP |
1 |
94,243,421 |
94,246,711 |
RGD:6480464 |
CTD |
| G |
Kpna6 |
karyopherin alpha 6 (importin alpha 7) |
|
affects expression |
EXP |
5 |
148,783,562 |
148,793,599 |
RGD:6480464 |
CTD |
| G |
Krt14 |
keratin 14 |
|
affects expression |
EXP |
10 |
89,144,357 |
89,148,415 |
RGD:6480464 |
CTD |
| G |
Krt19 |
keratin 19 |
|
affects expression |
EXP |
10 |
89,080,953 |
89,085,670 |
RGD:6480464 |
CTD |
| G |
Krt20 |
keratin 20 |
|
affects expression |
EXP |
10 |
88,335,894 |
88,379,899 |
RGD:6480464 |
CTD |
| G |
Krt78 |
keratin 78 |
|
affects expression |
EXP |
7 |
140,648,098 |
140,655,441 |
RGD:6480464 |
CTD |
| G |
Krtap14 |
keratin associated protein 14 |
|
affects expression |
EXP |
11 |
28,648,990 |
28,649,832 |
RGD:6480464 |
CTD |
| G |
Krtap16-5 |
keratin associated protein 16-5 |
|
affects expression |
EXP |
11 |
28,774,731 |
28,775,315 |
RGD:6480464 |
CTD |
| G |
Krtap3-3l1 |
keratin associated protein 3-3-like 1 |
|
affects expression |
EXP |
10 |
88,504,916 |
88,505,215 |
RGD:6480464 |
CTD |
| G |
Las1l |
LAS1-like (S. cerevisiae) |
|
affects expression |
EXP |
X |
83,568,652 |
83,590,289 |
RGD:6480464 |
CTD |
| G |
Lce1s |
late cornified envelope 1S |
|
affects expression |
EXP |
2 |
185,790,629 |
185,791,018 |
RGD:6480464 |
CTD |
| G |
Lgals1 |
lectin, galactoside-binding, soluble, 1 |
|
affects expression |
EXP |
7 |
116,893,662 |
116,896,768 |
RGD:6480464 |
CTD |
| G |
Lgals2 |
lectin, galactoside-binding, soluble, 2 |
|
affects expression |
EXP |
7 |
116,811,332 |
116,817,822 |
RGD:6480464 |
CTD |
| G |
Liph |
lipase, member H |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
LOC100360882 |
Mps one binder kinase activator-like 2 |
|
affects expression |
EXP |
1 |
202,138,589 |
202,195,526 |
RGD:6480464 |
CTD |
| G |
LOC100360940 |
diablo-like |
|
affects expression |
EXP |
5 |
148,562,065 |
148,563,619 |
RGD:6480464 |
CTD |
| G |
Lonrf1 |
LON peptidase N-terminal domain and ring finger 1 |
|
affects expression |
EXP |
16 |
59,651,010 |
59,703,999 |
RGD:6480464 |
CTD |
| G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
|
affects expression |
EXP |
1 |
15,205,361 |
15,346,422 |
RGD:6480464 |
CTD |
| G |
Mcam |
melanoma cell adhesion molecule |
|
affects expression |
EXP |
8 |
47,105,632 |
47,127,936 |
RGD:6480464 |
CTD |
| G |
Mef2bnb |
MEF2B neighbor |
|
affects expression |
EXP |
16 |
19,757,638 |
19,764,480 |
RGD:6480464 |
CTD |
| G |
Metap1d |
methionyl aminopeptidase type 1D (mitochondrial) |
|
affects expression |
EXP |
3 |
53,758,752 |
53,832,869 |
RGD:6480464 |
CTD |
| G |
Metrnl |
meteorin, glial cell differentiation regulator-like |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Mettl10 |
methyltransferase like 10 |
|
affects expression |
EXP |
1 |
192,296,932 |
192,320,995 |
RGD:6480464 |
CTD |
| G |
Mfap4 |
microfibrillar-associated protein 4 |
|
affects expression |
EXP |
10 |
47,646,157 |
47,649,095 |
RGD:6480464 |
CTD |
| G |
Mgme1 |
mitochondrial genome maintenance exonuclease 1 |
|
affects expression |
EXP |
3 |
132,798,031 |
132,806,688 |
RGD:6480464 |
CTD |
| G |
Mgst2 |
microsomal glutathione S-transferase 2 |
|
affects expression |
EXP |
2 |
140,546,939 |
140,568,616 |
RGD:6480464 |
CTD |
| G |
Mier1 |
mesoderm induction early response 1 homolog (Xenopus laevis) |
|
affects expression |
EXP |
5 |
124,053,388 |
124,100,875 |
RGD:6480464 |
CTD |
| G |
Mki67ip |
Mki67 (FHA domain) interacting nucleolar phosphoprotein |
|
affects expression |
EXP |
13 |
30,944,169 |
30,953,973 |
RGD:6480464 |
CTD |
| G |
Mmgt2 |
membrane magnesium transporter 2 |
|
affects expression |
EXP |
10 |
48,850,544 |
48,853,976 |
RGD:6480464 |
CTD |
| G |
Mmp12 |
matrix metallopeptidase 12 |
|
affects expression |
EXP |
8 |
4,249,938 |
4,259,675 |
RGD:6480464 |
CTD |
| G |
Mmp14 |
matrix metallopeptidase 14 (membrane-inserted) |
|
affects expression |
EXP |
15 |
32,493,852 |
32,503,077 |
RGD:6480464 |
CTD |
| G |
Mmp27 |
matrix metallopeptidase 27 |
|
affects expression |
EXP |
8 |
4,423,907 |
4,433,826 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mnd1 |
meiotic nuclear divisions 1 homolog (S. cerevisiae) |
|
affects expression |
EXP |
2 |
175,841,810 |
175,906,450 |
RGD:6480464 |
CTD |
| G |
Mob4 |
MOB family member 4, phocein |
|
affects expression |
EXP |
9 |
53,922,795 |
53,946,745 |
RGD:6480464 |
CTD |
| G |
Morn2 |
MORN repeat containing 2 |
|
affects expression |
EXP |
6 |
3,191,310 |
3,198,056 |
RGD:6480464 |
CTD |
| G |
Mospd1 |
motile sperm domain containing 1 |
|
affects expression |
EXP |
X |
140,301,920 |
140,329,537 |
RGD:6480464 |
CTD |
| G |
Mpp5 |
membrane protein, palmitoylated 5 (MAGUK p55 subfamily member 5) |
|
affects expression |
EXP |
6 |
101,414,657 |
101,471,504 |
RGD:6480464 |
CTD |
| G |
Mpped1 |
metallophosphoesterase domain containing 1 |
|
affects expression |
EXP |
7 |
121,816,012 |
121,883,681 |
RGD:6480464 |
CTD |
| G |
Mras |
muscle RAS oncogene homolog |
|
affects expression |
EXP |
8 |
104,244,660 |
104,272,556 |
RGD:6480464 |
CTD |
| G |
Msln |
mesothelin |
|
affects expression |
EXP |
10 |
15,017,162 |
15,022,823 |
RGD:6480464 |
CTD |
| G |
Mta3 |
metastasis associated 1 family, member 3 |
|
affects expression |
EXP |
6 6 |
7,060,212 7,060,212 |
7,180,405 7,180,405 |
RGD:6480464 |
CTD |
| G |
Mterfd1 |
MTERF domain containing 1 |
|
affects expression |
EXP |
7 |
67,969,806 |
67,988,047 |
RGD:6480464 |
CTD |
| G |
Mthfd2 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
|
affects expression |
EXP |
4 |
117,517,611 |
117,529,128 |
RGD:6480464 |
CTD |
| G |
Mto1 |
mitochondrial tRNA translation optimization 1 |
|
affects expression |
EXP |
8 |
83,444,213 |
83,457,260 |
RGD:6480464 |
CTD |
| G |
Muc1 |
mucin 1, cell surface associated |
|
decreases expression |
ISO |
2 |
181,399,482 |
181,403,640 |
RGD:6480464 |
CTD |
| G |
Muc1 |
mucin 1, cell surface associated |
|
affects expression |
EXP |
2 |
181,399,482 |
181,403,640 |
RGD:6480464 |
CTD |
| G |
Muc6 |
mucin 6, oligomeric mucus/gel-forming |
|
affects expression |
EXP |
1 |
201,815,833 |
201,837,239 |
RGD:6480464 |
CTD |
| G |
Mybph |
myosin binding protein H |
|
affects expression |
EXP |
13 |
47,151,091 |
47,158,665 |
RGD:6480464 |
CTD |
| G |
Myh10 |
myosin, heavy chain 10, non-muscle |
|
affects expression |
EXP |
10 |
55,445,288 |
55,576,096 |
RGD:6480464 |
CTD |
| G |
Myh14 |
myosin, heavy chain 14, non-muscle |
|
affects expression |
EXP |
1 |
95,081,948 |
95,146,449 |
RGD:6480464 |
CTD |
| G |
Myl6l |
myosin, light polypeptide 6, alkali, smooth muscle and non-muscle-like |
|
affects expression |
EXP |
13 |
29,671,403 |
29,672,085 |
RGD:6480464 |
CTD |
| G |
Myo7b |
myosin VIIb |
|
affects expression |
EXP |
18 |
24,382,252 |
24,463,999 |
RGD:6480464 |
CTD |
| G |
N4bp2l1 |
NEDD4 binding protein 2-like 1 |
|
affects expression |
EXP |
12 |
4,256,571 |
4,280,941 |
RGD:6480464 |
CTD |
| G |
Naa38 |
N(alpha)-acetyltransferase 38, NatC auxiliary subunit |
|
affects expression |
EXP |
4 |
44,717,003 |
44,722,869 |
RGD:6480464 |
CTD |
| G |
Nae1 |
NEDD8 activating enzyme E1 subunit 1 |
|
affects expression |
EXP |
19 |
382,556 |
408,667 |
RGD:6480464 |
CTD |
| G |
Ncam2 |
neural cell adhesion molecule 2 |
|
affects expression |
EXP |
11 |
20,409,948 |
20,911,422 |
RGD:6480464 |
CTD |
| G |
Ndufa7l |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7-like |
|
affects expression |
EXP |
3 |
55,312,099 |
55,312,440 |
RGD:6480464 |
CTD |
| G |
Ndufaf1 |
NADH dehydrogenase (ubiquinone) complex I, assembly factor 1 |
|
affects expression |
EXP |
3 |
106,171,381 |
106,181,742 |
RGD:6480464 |
CTD |
| G |
Nek4 |
NIMA-related kinase 4 |
|
affects expression |
EXP |
16 |
6,386,850 |
6,422,465 |
RGD:6480464 |
CTD |
| G |
Nenf |
neudesin neurotrophic factor |
|
affects expression |
EXP |
13 |
107,368,359 |
107,377,301 |
RGD:6480464 |
CTD |
| G |
Neu3 |
sialidase 3 (membrane sialidase) |
|
affects expression |
EXP |
1 |
157,172,027 |
157,183,064 |
RGD:6480464 |
CTD |
| G |
Neurl3 |
neuralized homolog 3 (Drosophila) |
|
affects expression |
EXP |
9 |
35,190,429 |
35,198,526 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
decreases activity |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
affects activity |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
affects expression |
EXP |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
decreases activity |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
decreases activity |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbil1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1 |
|
affects expression |
EXP |
20 |
3,629,246 |
3,644,222 |
RGD:6480464 |
CTD |
| G |
Ngfrap1 |
nerve growth factor receptor (TNFRSF16) associated protein 1 |
|
affects expression |
EXP |
X |
123,586,256 |
123,587,175 |
RGD:6480464 |
CTD |
| G |
Nipal2 |
NIPA-like domain containing 2 |
|
affects expression |
EXP |
7 |
70,021,792 |
70,135,156 |
RGD:6480464 |
CTD |
| G |
Nlrc4 |
NLR family, CARD domain containing 4 |
|
affects expression |
EXP |
6 |
20,934,595 |
20,953,654 |
RGD:6480464 |
CTD |
| G |
Nmral1 |
NmrA-like family domain containing 1 |
|
affects expression |
EXP |
10 |
10,971,190 |
10,979,379 |
RGD:6480464 |
CTD |
| G |
Nol3 |
nucleolar protein 3 (apoptosis repressor with CARD domain) |
|
affects expression |
EXP |
19 |
35,094,345 |
35,096,012 |
RGD:6480464 |
CTD |
| G |
Nop58 |
NOP58 ribonucleoprotein |
|
affects expression |
EXP |
9 |
58,255,685 |
58,279,522 |
RGD:6480464 |
CTD |
| G |
Notum |
notum pectinacetylesterase homolog (Drosophila) |
|
affects expression |
EXP |
10 |
110,047,040 |
110,054,106 |
RGD:6480464 |
CTD |
| G |
Npm3 |
nucleophosmin/nucleoplasmin, 3 |
|
affects expression |
EXP |
1 |
250,961,968 |
250,963,813 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases activity |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
affects expression |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
|
affects expression |
EXP |
10 |
87,541,246 |
87,548,186 |
RGD:6480464 |
CTD |
| G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
|
affects expression |
EXP |
7 |
140,012,807 |
140,020,590 |
RGD:6480464 |
CTD |
| G |
Nrep |
neuronal regeneration related protein |
|
affects expression |
EXP |
18 |
25,842,127 |
25,868,219 |
RGD:6480464 |
CTD |
| G |
Nrg1 |
neuregulin 1 |
|
affects expression |
EXP |
16 |
63,937,796 |
64,126,183 |
RGD:6480464 |
CTD |
| G |
Nt5m |
5',3'-nucleotidase, mitochondrial |
|
affects expression |
EXP |
10 |
46,174,806 |
46,200,790 |
RGD:6480464 |
CTD |
| G |
Ntf3 |
neurotrophin 3 |
|
affects expression |
EXP |
4 |
162,435,781 |
162,506,961 |
RGD:6480464 |
CTD |
| G |
Nudt15 |
nudix (nucleoside diphosphate linked moiety X)-type motif 15 |
|
affects expression |
EXP |
15 |
54,171,542 |
54,209,265 |
RGD:6480464 |
CTD |
| G |
Nupr1 |
nuclear protein, transcriptional regulator, 1 |
|
affects expression |
EXP |
1 |
185,770,310 |
185,772,313 |
RGD:6480464 |
CTD |
| G |
Nxn |
nucleoredoxin |
|
affects expression |
EXP |
10 |
67,775,938 |
67,913,018 |
RGD:6480464 |
CTD |
| G |
Oat |
ornithine aminotransferase |
|
affects expression |
EXP |
1 |
192,026,623 |
192,046,404 |
RGD:6480464 |
CTD |
| G |
Obp1f |
odorant binding protein I f |
|
affects expression |
EXP |
X |
63,689,823 |
63,696,729 |
RGD:6480464 |
CTD |
| G |
Obp3 |
alpha-2u globulin PGCL4 |
|
affects expression |
EXP |
5 |
78,088,876 |
78,092,317 |
RGD:6480464 |
CTD |
| G |
Odf2 |
outer dense fiber of sperm tails 2 |
|
affects expression |
EXP |
3 |
8,876,934 |
8,910,367 |
RGD:6480464 |
CTD |
| G |
Odf3b |
outer dense fiber of sperm tails 3B |
|
affects expression |
EXP |
7 |
127,671,982 |
127,674,607 |
RGD:6480464 |
CTD |
| G |
Ogn |
osteoglycin |
|
affects expression |
EXP |
17 |
20,987,029 |
21,007,525 |
RGD:6480464 |
CTD |
| G |
Olr104 |
olfactory receptor 104 |
|
affects expression |
EXP |
1 |
161,216,105 |
161,217,064 |
RGD:6480464 |
CTD |
| G |
Olr1083 |
olfactory receptor 1083 |
|
affects expression |
EXP |
7 |
12,227,724 |
12,228,656 |
RGD:6480464 |
CTD |
| G |
Olr1090 |
olfactory receptor 1090 |
|
affects expression |
EXP |
7 |
13,938,226 |
13,939,182 |
RGD:6480464 |
CTD |
| G |
Olr1093 |
olfactory receptor 1093 |
|
affects expression |
EXP |
7 |
14,175,378 |
14,176,334 |
RGD:6480464 |
CTD |
| G |
Olr1095 |
olfactory receptor 1095 |
|
affects expression |
EXP |
7 |
14,451,419 |
14,452,375 |
RGD:6480464 |
CTD |
| G |
Olr11 |
olfactory receptor 11 |
|
affects expression |
EXP |
1 |
141,497,722 |
141,498,669 |
RGD:6480464 |
CTD |
| G |
Olr1204 |
olfactory receptor 1204 |
|
affects expression |
EXP |
8 |
39,385,454 |
39,386,398 |
RGD:6480464 |
CTD |
| G |
Olr1302 |
olfactory receptor 1302 |
|
affects expression |
EXP |
8 |
42,322,123 |
42,323,067 |
RGD:6480464 |
CTD |
| G |
Olr1347 |
olfactory receptor 1347 |
|
affects expression |
EXP |
9 |
91,779,443 |
91,780,414 |
RGD:6480464 |
CTD |
| G |
Olr1381 |
olfactory receptor 1381 |
|
affects expression |
EXP |
10 |
12,706,761 |
12,707,702 |
RGD:6480464 |
CTD |
| G |
Olr1382 |
olfactory receptor 1382 |
|
affects expression |
EXP |
10 |
12,751,799 |
12,752,740 |
RGD:6480464 |
CTD |
| G |
Olr1385 |
olfactory receptor 1385 |
|
affects expression |
EXP |
10 |
34,279,874 |
34,280,821 |
RGD:6480464 |
CTD |
| G |
Olr139 |
olfactory receptor 139 |
|
affects expression |
EXP |
1 |
161,825,908 |
161,826,855 |
RGD:6480464 |
CTD |
| G |
Olr1394 |
olfactory receptor 1394 |
|
affects expression |
EXP |
10 |
34,863,367 |
34,864,296 |
RGD:6480464 |
CTD |
| G |
Olr1398 |
olfactory receptor 1398 |
|
affects expression |
EXP |
10 |
34,940,774 |
34,941,709 |
RGD:6480464 |
CTD |
| G |
Olr140 |
olfactory receptor 140 |
|
affects expression |
EXP |
1 |
161,851,927 |
161,852,874 |
RGD:6480464 |
CTD |
| G |
Olr1416 |
olfactory receptor 1416 |
|
affects expression |
EXP |
10 |
44,148,021 |
44,148,950 |
RGD:6480464 |
CTD |
| G |
Olr1422 |
olfactory receptor 1422 |
|
affects expression |
EXP |
10 |
44,322,908 |
44,323,852 |
RGD:6480464 |
CTD |
| G |
Olr1424 |
olfactory receptor 1424 |
|
affects expression |
EXP |
10 |
44,385,720 |
44,386,658 |
RGD:6480464 |
CTD |
| G |
Olr1428 |
olfactory receptor 1428 |
|
affects expression |
EXP |
10 |
44,427,477 |
44,428,424 |
RGD:6480464 |
CTD |
| G |
Olr1435 |
olfactory receptor 1435 |
|
affects expression |
EXP |
10 |
44,590,716 |
44,591,633 |
RGD:6480464 |
CTD |
| G |
Olr1439 |
olfactory receptor 1439 |
|
affects expression |
EXP |
10 |
44,703,738 |
44,704,658 |
RGD:6480464 |
CTD |
| G |
Olr1451 |
olfactory receptor 1451 |
|
affects expression |
EXP |
10 |
44,937,699 |
44,938,628 |
RGD:6480464 |
CTD |
| G |
Olr1455 |
olfactory receptor 1455 |
|
affects expression |
EXP |
10 |
44,997,581 |
44,998,510 |
RGD:6480464 |
CTD |
| G |
Olr1481 |
olfactory receptor 1481 |
|
affects expression |
EXP |
10 |
60,581,677 |
60,582,621 |
RGD:6480464 |
CTD |
| G |
Olr1492 |
olfactory receptor 1492 |
|
affects expression |
EXP |
10 |
60,888,043 |
60,888,981 |
RGD:6480464 |
CTD |
| G |
Olr1531 |
olfactory receptor 1531 |
|
affects expression |
EXP |
11 |
41,811,138 |
41,812,055 |
RGD:6480464 |
CTD |
| G |
Olr1633 |
olfactory receptor 1633 |
|
affects expression |
EXP |
15 |
26,638,505 |
26,639,437 |
RGD:6480464 |
CTD |
| G |
Olr1670 |
olfactory receptor 1670 |
|
affects expression |
EXP |
20 |
164,658 |
165,596 |
RGD:6480464 |
CTD |
| G |
Olr1697 |
olfactory receptor 1697 |
|
affects expression |
EXP |
20 |
710,764 |
711,729 |
RGD:6480464 |
CTD |
| G |
Olr1742 |
olfactory receptor 1742 |
|
affects expression |
EXP |
20 |
1,437,944 |
1,438,873 |
RGD:6480464 |
CTD |
| G |
Olr181 |
olfactory receptor 181 |
|
affects expression |
EXP |
1 |
162,772,333 |
162,773,271 |
RGD:6480464 |
CTD |
| G |
Olr1878 |
olfactory receptor 1878 |
|
affects expression |
EXP |
15 |
26,056,452 |
26,061,415 |
RGD:6480464 |
CTD |
| G |
Olr378 |
olfactory receptor 378 |
|
affects expression |
EXP |
1 |
216,913,171 |
216,914,133 |
RGD:6480464 |
CTD |
| G |
Olr736 |
olfactory receptor 736 |
|
affects expression |
EXP |
3 |
74,579,599 |
74,580,528 |
RGD:6480464 |
CTD |
| G |
Olr780 |
olfactory receptor 780 |
|
affects expression |
EXP |
3 |
97,522,090 |
97,523,028 |
RGD:6480464 |
CTD |
| G |
Olr803 |
olfactory receptor 803 |
|
affects expression |
EXP |
4 |
70,272,395 |
70,273,333 |
RGD:6480464 |
CTD |
| G |
Olr824 |
olfactory receptor 824 |
|
affects expression |
EXP |
4 |
152,732,267 |
152,733,250 |
RGD:6480464 |
CTD |
| G |
Olr826 |
olfactory receptor 826 |
|
affects expression |
EXP |
4 |
152,781,832 |
152,782,815 |
RGD:6480464 |
CTD |
| G |
Olr855 |
olfactory receptor 855 |
|
affects expression |
EXP |
5 |
139,134,784 |
139,135,731 |
RGD:6480464 |
CTD |
| G |
Olr856 |
olfactory receptor 856 |
|
affects expression |
EXP |
5 |
139,153,024 |
139,153,962 |
RGD:6480464 |
CTD |
| G |
Olr865 |
olfactory receptor 865 |
|
affects expression |
EXP |
5 |
139,347,124 |
139,348,071 |
RGD:6480464 |
CTD |
| G |
Olr869 |
olfactory receptor 869 |
|
affects expression |
EXP |
5 |
139,462,383 |
139,463,330 |
RGD:6480464 |
CTD |
| G |
Olr883 |
olfactory receptor 883 |
|
affects expression |
EXP |
7 |
2,642,386 |
2,643,321 |
RGD:6480464 |
CTD |
| G |
Olr917 |
olfactory receptor 917 |
|
affects expression |
EXP |
7 |
3,973,798 |
3,974,733 |
RGD:6480464 |
CTD |
| G |
Omd |
osteomodulin |
|
affects expression |
EXP |
17 |
21,015,178 |
21,023,126 |
RGD:6480464 |
CTD |
| G |
Orc3 |
origin recognition complex, subunit 3 |
|
affects expression |
EXP |
5 |
51,172,243 |
51,226,644 |
RGD:6480464 |
CTD |
| G |
Oscp1 |
organic solute carrier partner 1 |
|
affects expression |
EXP |
5 |
145,410,786 |
145,441,442 |
RGD:6480464 |
CTD |
| G |
Osgep |
O-sialoglycoprotein endopeptidase |
|
affects expression |
EXP |
15 |
26,896,592 |
26,904,011 |
RGD:6480464 |
CTD |
| G |
Osgepl1 |
O-sialoglycoprotein endopeptidase-like 1 |
|
affects expression |
EXP |
9 |
45,164,778 |
45,178,715 |
RGD:6480464 |
CTD |
| G |
Palm |
paralemmin |
|
affects expression |
EXP |
7 |
11,399,529 |
11,425,964 |
RGD:6480464 |
CTD |
| G |
Pamr1 |
peptidase domain containing associated with muscle regeneration 1 |
|
affects expression |
EXP |
3 |
87,754,805 |
87,847,008 |
RGD:6480464 |
CTD |
| G |
Pank3 |
pantothenate kinase 3 |
|
affects expression |
EXP |
10 |
20,679,354 |
20,699,173 |
RGD:6480464 |
CTD |
| G |
Panx2 |
pannexin 2 |
|
affects expression |
EXP |
7 |
127,364,190 |
127,374,412 |
RGD:6480464 |
CTD |
| G |
Papss2 |
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
|
affects expression |
EXP |
1 |
236,592,414 |
236,677,379 |
RGD:6480464 |
CTD |
| G |
Paqr7 |
progestin and adipoQ receptor family member VII |
|
affects expression |
EXP |
5 |
153,263,432 |
153,264,469 |
RGD:6480464 |
CTD |
| G |
Paqr9 |
progestin and adipoQ receptor family member IX |
|
affects expression |
EXP |
8 |
100,650,642 |
100,651,700 |
RGD:6480464 |
CTD |
| G |
Park2 |
parkinson protein 2, E3 ubiquitin protein ligase |
|
affects expression |
EXP |
1 |
43,151,265 |
44,374,470 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pbdc1 |
polysaccharide biosynthesis domain containing 1 |
|
affects expression |
EXP |
X |
93,151,907 |
93,156,607 |
RGD:6480464 |
CTD |
| G |
Pbxip1 |
pre-B-cell leukemia homeobox interacting protein 1 |
|
affects expression |
EXP |
2 |
181,637,864 |
181,647,769 |
RGD:6480464 |
CTD |
| G |
Pcsk5 |
proprotein convertase subtilisin/kexin type 5 |
|
affects expression |
EXP |
1 |
220,961,912 |
221,405,907 |
RGD:6480464 |
CTD |
| G |
Pde3b |
phosphodiesterase 3B, cGMP-inhibited |
|
affects expression |
EXP |
1 |
172,409,282 |
172,577,108 |
RGD:6480464 |
CTD |
| G |
Pdgfa |
platelet-derived growth factor alpha polypeptide |
|
affects expression |
EXP |
12 |
16,151,045 |
16,172,412 |
RGD:6480464 |
CTD |
| G |
Pdha2 |
pyruvate dehydrogenase (lipoamide) alpha 2 |
|
affects expression |
EXP |
2 |
238,983,103 |
238,984,651 |
RGD:6480464 |
CTD |
| G |
Pex11g |
peroxisomal biogenesis factor 11 gamma |
|
affects expression |
EXP |
12 |
2,702,761 |
2,709,897 |
RGD:6480464 |
CTD |
| G |
Pfkm |
phosphofructokinase, muscle |
|
affects expression |
EXP |
7 |
136,826,122 |
136,846,040 |
RGD:6480464 |
CTD |
| G |
Pfkp |
phosphofructokinase, platelet |
|
affects expression |
EXP |
17 |
74,760,912 |
74,823,046 |
RGD:6480464 |
CTD |
| G |
Phgdh |
phosphoglycerate dehydrogenase |
|
affects expression |
EXP |
2 |
193,147,943 |
193,177,137 |
RGD:6480464 |
CTD |
| G |
Pibf1 |
progesterone immunomodulatory binding factor 1 |
|
affects expression |
EXP |
15 |
82,881,953 |
83,056,944 |
RGD:6480464 |
CTD |
| G |
Plau |
plasminogen activator, urokinase |
|
increases expression |
ISO |
15 |
3,680,072 |
3,686,232 |
RGD:6480464 |
CTD |
| G |
Plgrkt |
plasminogen receptor, C-terminal lysine transmembrane protein |
|
affects expression |
EXP |
1 |
233,030,393 |
233,042,659 |
RGD:6480464 |
CTD |
| G |
Plxdc2 |
plexin domain containing 2 |
|
affects expression |
EXP |
17 |
90,572,391 |
90,982,074 |
RGD:6480464 |
CTD |
| G |
Ppp1r1b |
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
|
affects expression |
EXP |
10 |
87,121,889 |
87,131,587 |
RGD:6480464 |
CTD |
| G |
Prkcdbp |
protein kinase C, delta binding protein |
|
affects expression |
EXP |
1 |
163,212,922 |
163,214,511 |
RGD:6480464 |
CTD |
| G |
Prlr |
prolactin receptor |
|
affects expression |
EXP |
2 |
59,507,966 |
59,701,221 |
RGD:6480464 |
CTD |
| G |
Prodh2 |
proline dehydrogenase (oxidase) 2 |
|
affects expression |
EXP |
1 |
85,546,014 |
85,559,530 |
RGD:6480464 |
CTD |
| G |
Prol1 |
proline rich, lacrimal 1 |
|
affects expression |
EXP |
14 |
21,294,053 |
21,308,816 |
RGD:6480464 |
CTD |
| G |
Prrg4 |
proline rich Gla (G-carboxyglutamic acid) 4 (transmembrane) |
|
affects expression |
EXP |
3 |
90,174,070 |
90,198,654 |
RGD:6480464 |
CTD |
| G |
Prss32 |
protease, serine, 32 |
|
affects expression |
EXP |
10 |
13,119,051 |
13,125,902 |
RGD:6480464 |
CTD |
| G |
Psat1 |
phosphoserine aminotransferase 1 |
|
affects expression |
EXP |
1 |
219,268,419 |
219,290,273 |
RGD:6480464 |
CTD |
| G |
Psmc3ip |
PSMC3 interacting protein |
|
affects expression |
EXP |
10 |
90,108,909 |
90,112,013 |
RGD:6480464 |
CTD |
| G |
Pspc1 |
paraspeckle component 1 |
|
affects expression |
EXP |
15 |
35,718,357 |
35,779,139 |
RGD:6480464 |
CTD |
| G |
Psx1 |
placenta specific homeobox 1 |
|
affects expression |
EXP |
3 |
1,692,796 |
1,693,467 |
RGD:6480464 |
CTD |
| G |
Ptar1 |
protein prenyltransferase alpha subunit repeat containing 1 |
|
affects expression |
EXP |
1 |
227,024,689 |
227,069,914 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptp4a3 |
protein tyrosine phosphatase type IVA, member 3 |
|
affects expression |
EXP |
7 |
111,462,191 |
111,468,045 |
RGD:6480464 |
CTD |
| G |
Ptpla |
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member a |
|
affects expression |
EXP |
17 |
88,239,568 |
88,253,571 |
RGD:6480464 |
CTD |
| G |
Pttg1 |
pituitary tumor-transforming 1 |
|
affects expression |
EXP |
10 |
28,527,409 |
28,532,831 |
RGD:6480464 |
CTD |
| G |
PVR |
poliovirus receptor |
|
affects expression |
EXP |
1 |
79,213,654 |
79,229,063 |
RGD:6480464 |
CTD |
| G |
Pyroxd1 |
pyridine nucleotide-disulphide oxidoreductase domain 1 |
|
affects expression |
EXP |
4 |
179,910,953 |
179,927,331 |
RGD:6480464 |
CTD |
| G |
Qrich1 |
glutamine-rich 1 |
|
affects expression |
EXP |
8 |
113,564,863 |
113,606,732 |
RGD:6480464 |
CTD |
| G |
Rab13 |
RAB13, member RAS oncogene family |
|
affects expression |
EXP |
2 |
182,460,998 |
182,465,393 |
RGD:6480464 |
CTD |
| G |
Rad1 |
RAD1 homolog (S. pombe) |
|
affects expression |
EXP |
2 |
59,837,934 |
59,845,973 |
RGD:6480464 |
CTD |
| G |
Rad50 |
RAD50 homolog (S. cerevisiae) |
|
affects expression |
EXP |
10 |
39,112,733 |
39,164,694 |
RGD:6480464 |
CTD |
| G |
Ramp2 |
receptor (G protein-coupled) activity modifying protein 2 |
|
affects expression |
EXP |
10 |
90,275,463 |
90,277,242 |
RGD:6480464 |
CTD |
| G |
Ramp3 |
receptor (G protein-coupled) activity modifying protein 3 |
|
affects expression |
EXP |
14 |
87,417,290 |
87,434,789 |
RGD:6480464 |
CTD |
| G |
Rassf1 |
Ras association (RalGDS/AF-6) domain family member 1 |
|
affects expression |
EXP |
8 |
112,798,863 |
112,810,004 |
RGD:6480464 |
CTD |
| G |
Rbbp4 |
retinoblastoma binding protein 4 |
|
affects expression |
EXP |
5 |
148,472,397 |
148,492,172 |
RGD:6480464 |
CTD |
| G |
Rbm12 |
RNA binding motif protein 12 |
|
affects expression |
EXP |
3 |
146,504,101 |
146,521,424 |
RGD:6480464 |
CTD |
| G |
Rbm43 |
RNA binding motif protein 43 |
|
affects expression |
EXP |
3 |
32,938,135 |
32,958,882 |
RGD:6480464 |
CTD |
| G |
Rbms2 |
RNA binding motif, single stranded interacting protein 2 |
|
affects expression |
EXP |
7 |
1,426,634 |
1,462,518 |
RGD:6480464 |
CTD |
| G |
Reep5 |
receptor accessory protein 5 |
|
affects expression |
EXP |
18 |
26,813,889 |
26,845,178 |
RGD:6480464 |
CTD |
| G |
Reep6 |
receptor accessory protein 6 |
|
affects expression |
EXP |
7 |
10,885,266 |
10,891,936 |
RGD:6480464 |
CTD |
| G |
Reg4 |
regenerating islet-derived family, member 4 |
|
affects expression |
EXP |
2 |
193,066,427 |
193,077,988 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
decreases activity |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
decreases activity |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
decreases activity |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rell1 |
RELT-like 1 |
|
affects expression |
EXP |
14 |
47,179,973 |
47,229,627 |
RGD:6480464 |
CTD |
| G |
Renbp |
renin binding protein |
|
affects expression |
EXP |
X |
159,849,355 |
159,858,288 |
RGD:6480464 |
CTD |
| G |
Rfc4 |
replication factor C (activator 1) 4 |
|
affects expression |
EXP |
11 |
79,935,273 |
79,950,589 |
RGD:6480464 |
CTD |
| G |
RGD1305420 |
similar to Nef associated protein 1 |
|
affects expression |
EXP |
5 |
62,943,064 |
62,951,845 |
RGD:6480464 |
CTD |
| G |
RGD1305593 |
similar to RIKEN cDNA 1810042K04 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
RGD1305928 |
hypothetical LOC300207 |
|
affects expression |
EXP |
7 |
137,317,938 |
137,339,581 |
RGD:6480464 |
CTD |
| G |
RGD1306474 |
similar to RIKEN cDNA 9530003J23 |
|
affects expression |
EXP |
7 |
56,576,837 |
56,581,709 |
RGD:6480464 |
CTD |
| G |
RGD1306556 |
similar to hypothetical protein A530094D01 |
|
affects expression |
EXP |
12 |
44,451,049 |
44,559,584 |
RGD:6480464 |
CTD |
| G |
RGD1306626 |
similar to RIKEN cDNA 4930500J03 |
|
affects expression |
EXP |
4 |
27,181,841 |
27,214,444 |
RGD:6480464 |
CTD |
| G |
RGD1306739 |
similar to RIKEN cDNA 1700040L02 |
|
affects expression |
EXP |
20 |
20,871,970 |
20,981,865 |
RGD:6480464 |
CTD |
| G |
RGD1308114 |
similar to cDNA sequence AF397014 |
|
affects expression |
EXP |
17 |
55,271,485 |
56,354,931 |
RGD:6480464 |
CTD |
| G |
RGD1309077 |
similar to putative RNA methyltransferase |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
RGD1309362 |
similar to interferon-inducible GTPase |
|
affects expression |
EXP |
18 |
56,154,355 |
56,179,809 |
RGD:6480464 |
CTD |
| G |
RGD1309651 |
similar to 1190005I06Rik protein |
|
affects expression |
EXP |
19 |
50,963,265 |
50,989,667 |
RGD:6480464 |
CTD |
| G |
RGD1309730 |
similar to RIKEN cDNA B230118H07 |
|
affects expression |
EXP |
3 |
86,659,453 |
86,769,728 |
RGD:6480464 |
CTD |
| G |
RGD1309779 |
similar to ENSANGP00000021391 |
|
affects expression |
EXP |
8 |
67,558,904 |
67,563,530 |
RGD:6480464 |
CTD |
| G |
RGD1310209 |
similar to KIAA1324 protein |
|
affects expression |
EXP |
2 |
204,016,795 |
204,085,212 |
RGD:6480464 |
CTD |
| G |
RGD1310262 |
hypothetical LOC304650 |
|
affects expression |
EXP |
19 |
25,826,018 |
25,827,979 |
RGD:6480464 |
CTD |
| G |
RGD1310647 |
similar to isopentenyl diphosphate delta-isomerase type 2 |
|
affects expression |
EXP |
17 |
72,274,978 |
72,288,445 |
RGD:6480464 |
CTD |
| G |
RGD1311739 |
similar to RIKEN cDNA 1700037H04 |
|
affects expression |
EXP |
3 |
118,851,409 |
118,865,511 |
RGD:6480464 |
CTD |
| G |
RGD1311946 |
similar to RIKEN cDNA 1810055G02 |
|
affects expression |
EXP |
1 |
206,234,532 |
206,243,241 |
RGD:6480464 |
CTD |
| G |
RGD1559459 |
similar to Expressed sequence AI788959 |
|
affects expression |
EXP |
14 |
22,768,551 |
22,786,094 |
RGD:6480464 |
CTD |
| G |
RGD1559494 |
RGD1559494 |
|
affects expression |
EXP |
2 |
52,042,551 |
52,049,469 |
RGD:6480464 |
CTD |
| G |
RGD1559508 |
similar to hypothetical protein 4930474N05 |
|
affects expression |
EXP |
16 |
11,761,318 |
11,776,787 |
RGD:6480464 |
CTD |
| G |
RGD1559532 |
RGD1559532 |
|
affects expression |
EXP |
4 |
169,787,822 |
169,822,133 |
RGD:6480464 |
CTD |
| G |
RGD1559545 |
similar to ATPase inhibitory factor 1 |
|
affects expression |
EXP |
6 |
93,454,394 |
93,454,929 |
RGD:6480464 |
CTD |
| G |
RGD1559590 |
similar to glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) (EC 1.2.1.12) |
|
affects expression |
EXP |
11 |
69,272,374 |
69,278,008 |
RGD:6480464 |
CTD |
| G |
RGD1559600 |
RGD1559600 |
|
affects expression |
EXP |
1 |
177,887,740 |
177,899,508 |
RGD:6480464 |
CTD |
| G |
RGD1559628 |
similar to RIKEN cDNA 1110003E01 |
|
affects expression |
EXP |
15 |
6,069,695 |
6,069,994 |
RGD:6480464 |
CTD |
| G |
RGD1559699 |
similar to putative protein kinase |
|
affects expression |
EXP |
1 |
51,233,291 |
51,269,328 |
RGD:6480464 |
CTD |
| G |
RGD1559808 |
similar to 40S ribosomal protein S26 |
|
affects expression |
EXP |
9 |
2,011,520 |
2,011,867 |
RGD:6480464 |
CTD |
| G |
RGD1559834 |
similar to ribosomal protein L5 |
|
affects expression |
EXP |
X |
69,385,961 |
69,387,074 |
RGD:6480464 |
CTD |
| G |
RGD1559837 |
similar to TDPOZ2 |
|
affects expression |
EXP |
2 |
189,088,093 |
189,089,195 |
RGD:6480464 |
CTD |
| G |
RGD1559932 |
similar to interferon alpha 8/6 precursor; IFNa8/6 (B6) |
|
affects expression |
EXP |
5 |
108,328,742 |
108,329,296 |
RGD:6480464 |
CTD |
| G |
RGD1559946 |
similar to putative protein kinase |
|
affects expression |
EXP |
1 |
51,857,307 |
51,860,517 |
RGD:6480464 |
CTD |
| G |
RGD1560000 |
similar to alpha tubulin |
|
affects expression |
EXP |
2 |
194,201,443 |
194,201,670 |
RGD:6480464 |
CTD |
| G |
RGD1560019 |
similar to hypothetical protein |
|
affects expression |
EXP |
8 |
86,896,143 |
86,897,363 |
RGD:6480464 |
CTD |
| G |
RGD1560060 |
similar to Gene model 784 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
RGD1560076 |
similar to 60S ribosomal protein L29 (P23) |
|
affects expression |
EXP |
2 |
39,456,626 |
39,457,096 |
RGD:6480464 |
CTD |
| G |
RGD1560095 |
similar to double homeobox, 4 |
|
affects expression |
EXP |
20 |
38,442,153 |
38,443,010 |
RGD:6480464 |
CTD |
| G |
RGD1560135 |
similar to double homeobox, 4 |
|
affects expression |
EXP |
20 |
38,261,579 |
38,262,436 |
RGD:6480464 |
CTD |
| G |
RGD1560140 |
similar to double homeobox, 4 |
|
affects expression |
EXP |
20 |
38,383,929 |
38,384,504 |
RGD:6480464 |
CTD |
| G |
RGD1560164 |
similar to hypothetical protein |
|
affects expression |
EXP |
10 |
53,588,109 |
53,588,432 |
RGD:6480464 |
CTD |
| G |
RGD1560209 |
similar to MAP/microtubule affinity-regulating kinase 4 (MAP/microtubule affinity-regulating kinase like 1) |
|
affects expression |
EXP |
17 |
97,220,556 |
97,221,985 |
RGD:6480464 |
CTD |
| G |
RGD1560221 |
similar to serine/threonine kinase |
|
affects expression |
EXP |
17 |
68,203,000 |
68,230,353 |
RGD:6480464 |
CTD |
| G |
RGD1560270 |
RGD1560270 |
|
affects expression |
EXP |
4 |
175,835,149 |
175,835,586 |
RGD:6480464 |
CTD |
| G |
RGD1560299 |
similar to mKIAA0615 protein |
|
affects expression |
EXP |
4 |
17,073,020 |
17,079,501 |
RGD:6480464 |
CTD |
| G |
RGD1560485 |
RGD1560485 |
|
affects expression |
EXP |
1 |
52,802,714 |
52,815,803 |
RGD:6480464 |
CTD |
| G |
RGD1560516 |
RGD1560516 |
|
affects expression |
EXP |
1 |
50,855,963 |
50,867,890 |
RGD:6480464 |
CTD |
| G |
RGD1560539 |
similar to interferon alpha 8/6 precursor; IFNa8/6 (B6) |
|
affects expression |
EXP |
5 |
108,312,518 |
108,313,072 |
RGD:6480464 |
CTD |
| G |
RGD1560543 |
similar to Afadin (AF-6 protein) |
|
affects expression |
EXP |
1 |
51,331,186 |
51,391,836 |
RGD:6480464 |
CTD |
| G |
RGD1560554 |
similar to TDPOZ2 |
|
affects expression |
EXP |
2 |
188,926,234 |
188,927,336 |
RGD:6480464 |
CTD |
| G |
RGD1560555 |
similar to double homeobox, 4 |
|
affects expression |
EXP |
20 |
36,939,907 |
36,940,742 |
RGD:6480464 |
CTD |
| G |
RGD1560570 |
similar to spermatogenesis associated glutamate (E)-rich protein 4b |
|
affects expression |
EXP |
8 |
40,130,335 |
40,134,810 |
RGD:6480464 |
CTD |
| G |
RGD1560580 |
similar to spermiogenesis specific transcript on the Y 2 |
|
affects expression |
EXP |
12 |
31,880,615 |
31,881,481 |
RGD:6480464 |
CTD |
| G |
RGD1560617 |
hypothetical gene supported by NM_053561; AF062594 |
|
affects expression |
EXP |
7 |
125,217,667 |
125,300,755 |
RGD:6480464 |
CTD |
| G |
RGD1560648 |
similar to DJ-1 protein |
|
affects expression |
EXP |
16 |
42,629,618 |
42,629,947 |
RGD:6480464 |
CTD |
| G |
RGD1560663 |
similar to mKIAA0615 protein |
|
affects expression |
EXP |
1 |
149,783,736 |
149,786,097 |
RGD:6480464 |
CTD |
| G |
RGD1560677 |
similar to dentin phosphoryn |
|
affects expression |
EXP |
16 |
21,185,805 |
21,188,672 |
RGD:6480464 |
CTD |
| G |
RGD1560683 |
similar to 40S ribosomal protein S21 |
|
affects expression |
EXP |
2 |
129,356,850 |
129,357,104 |
RGD:6480464 |
CTD |
| G |
RGD1560718 |
similar to putative protein kinase |
|
affects expression |
EXP |
1 |
48,397,215 |
48,398,720 |
RGD:6480464 |
CTD |
| G |
RGD1560777 |
similar to hypothetical protein MGC67567 |
|
affects expression |
EXP |
20 |
37,990,311 |
37,991,145 |
RGD:6480464 |
CTD |
| G |
RGD1560805 |
similar to isopentenyl diphosphate delta-isomerase type 2 |
|
affects expression |
EXP |
17 |
72,139,854 |
72,142,398 |
RGD:6480464 |
CTD |
| G |
RGD1560808 |
similar to putative protein kinase |
|
affects expression |
EXP |
1 |
52,579,077 |
52,605,693 |
RGD:6480464 |
CTD |
| G |
RGD1560826 |
similar to glyceraldehyde-3-phosphate dehydrogenase |
|
affects expression |
EXP |
2 |
219,334,251 |
219,335,258 |
RGD:6480464 |
CTD |
| G |
RGD1560918 |
similar to RIKEN cDNA 1700001F09 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
RGD1560972 |
similar to putative protein kinase |
|
affects expression |
EXP |
1 |
50,347,686 |
50,367,846 |
RGD:6480464 |
CTD |
| G |
RGD1561042 |
similar to RIKEN cDNA 5730509K17 gene |
|
affects expression |
EXP |
14 |
72,514,369 |
72,593,323 |
RGD:6480464 |
CTD |
| G |
RGD1561089 |
RGD1561089 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
RGD1561114 |
similar to hypothetical protein 4930474N05 |
|
affects expression |
EXP |
18 |
42,149,482 |
42,151,099 |
RGD:6480464 |
CTD |
| G |
RGD1561155 |
similar to putative protein kinase |
|
affects expression |
EXP |
1 |
52,938,631 |
52,952,815 |
RGD:6480464 |
CTD |
| G |
RGD1561185 |
similar to putative protein kinase |
|
affects expression |
EXP |
1 |
48,958,706 |
48,960,347 |
RGD:6480464 |
CTD |
| G |
RGD1561216 |
similar to Discs, large homolog 5 (Placenta and prostate DLG) |
|
affects expression |
EXP |
8 |
41,819,339 |
41,822,955 |
RGD:6480464 |
CTD |
| G |
RGD1561231 |
similar to MAP/microtubule affinity-regulating kinase 4 (MAP/microtubule affinity-regulating kinase like 1) |
|
affects expression |
EXP |
17 |
97,130,120 |
97,214,876 |
RGD:6480464 |
CTD |
| G |
RGD1561273 |
similar to spermatogenesis associated glutamate (E)-rich protein 4b |
|
affects expression |
EXP |
8 |
39,789,712 |
39,794,534 |
RGD:6480464 |
CTD |
| G |
RGD1561305 |
RGD1561305 |
|
affects expression |
EXP |
7 |
17,751,102 |
17,785,972 |
RGD:6480464 |
CTD |
| G |
RGD1561306 |
similar to immunoreceptor Ly49si3 |
|
affects expression |
EXP |
4 |
167,359,361 |
167,376,393 |
RGD:6480464 |
CTD |
| G |
RGD1561314 |
similar to Ac1147 |
|
affects expression |
EXP |
2 |
608,741 |
612,603 |
RGD:6480464 |
CTD |
| G |
RGD1561339 |
similar to putative protein kinase |
|
affects expression |
EXP |
1 |
52,531,726 |
52,545,747 |
RGD:6480464 |
CTD |
| G |
RGD1561388 |
similar to Afadin (Af-6 protein) |
|
affects expression |
EXP |
1 |
51,039,169 |
51,043,499 |
RGD:6480464 |
CTD |
| G |
RGD1561393 |
similar to CG15133-PA |
|
affects expression |
EXP |
2 |
123,424,693 |
123,438,513 |
RGD:6480464 |
CTD |
| G |
RGD1561401 |
similar to double homeobox, 4 |
|
affects expression |
EXP |
20 |
36,897,585 |
36,898,844 |
RGD:6480464 |
CTD |
| G |
RGD1561446 |
similar to putative protein kinase |
|
affects expression |
EXP |
1 |
50,882,334 |
50,888,281 |
RGD:6480464 |
CTD |
| G |
RGD1561493 |
similar to MAP/microtubule affinity-regulating kinase 4 (MAP/microtubule affinity-regulating kinase like 1) |
|
affects expression |
EXP |
17 |
68,034,932 |
68,053,489 |
RGD:6480464 |
CTD |
| G |
RGD1561542 |
similar to hypothetical protein DKFZp434P0316 |
|
affects expression |
EXP |
5 |
119,958,065 |
119,983,691 |
RGD:6480464 |
CTD |
| G |
RGD1561546 |
similar to serine/threonine kinase |
|
affects expression |
EXP |
17 |
68,091,251 |
68,094,180 |
RGD:6480464 |
CTD |
| G |
RGD1561557 |
similar to chromosome 21 open reading frame 29 |
|
affects expression |
EXP |
20 |
11,202,367 |
11,203,780 |
RGD:6480464 |
CTD |
| G |
RGD1561558 |
similar to RIKEN cDNA 1700001F22 |
|
affects expression |
EXP |
X |
139,896,745 |
139,897,306 |
RGD:6480464 |
CTD |
| G |
RGD1561594 |
similar to testis-specific farnesyl pyrophosphate synthetase |
|
affects expression |
EXP |
X |
27,868,577 |
27,869,688 |
RGD:6480464 |
CTD |
| G |
RGD1561620 |
similar to isopentenyl diphosphate delta-isomerase type 2 |
|
affects expression |
EXP |
17 |
72,351,914 |
72,354,384 |
RGD:6480464 |
CTD |
| G |
RGD1561627 |
similar to hypothetical protein 4930474N05 |
|
affects expression |
EXP |
18 |
42,136,999 |
42,138,639 |
RGD:6480464 |
CTD |
| G |
RGD1561654 |
similar to hypothetical protein |
|
affects expression |
EXP |
2 |
245,736,776 |
245,737,345 |
RGD:6480464 |
CTD |
| G |
RGD1561656 |
similar to putative mitochondrial protein (2B324) |
|
affects expression |
EXP |
18 |
2,315,818 |
2,317,857 |
RGD:6480464 |
CTD |
| G |
RGD1561667 |
similar to putative protein kinase |
|
affects expression |
EXP |
1 |
48,961,370 |
48,971,077 |
RGD:6480464 |
CTD |
| G |
RGD1561684 |
similar to keratin associated protein 2-4 |
|
affects expression |
EXP |
10 |
88,575,672 |
88,576,064 |
RGD:6480464 |
CTD |
| G |
RGD1561705 |
RGD1561705 |
|
affects expression |
EXP |
1 |
202,309,551 |
202,310,390 |
RGD:6480464 |
CTD |
| G |
RGD1561706 |
similar to putative protein kinase |
|
affects expression |
EXP |
1 |
50,429,249 |
50,433,131 |
RGD:6480464 |
CTD |
| G |
RGD1561759 |
similar to putative protein kinase |
|
affects expression |
EXP |
1 |
51,956,332 |
51,957,195 |
RGD:6480464 |
CTD |
| G |
RGD1561834 |
similar to Irx2 protein |
|
affects expression |
EXP |
X |
81,306,448 |
81,307,087 |
RGD:6480464 |
CTD |
| G |
RGD1561874 |
similar to putative protein kinase |
|
affects expression |
EXP |
1 |
49,997,386 |
50,035,868 |
RGD:6480464 |
CTD |
| G |
RGD1561875 |
similar to ribosomal protein L21 |
|
affects expression |
EXP |
2 |
228,247,136 |
228,247,618 |
RGD:6480464 |
CTD |
| G |
RGD1561881 |
similar to glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) (EC 1.2.1.12) |
|
affects expression |
EXP |
1 |
222,793,953 |
222,794,969 |
RGD:6480464 |
CTD |
| G |
RGD1561919 |
similar to ribosomal protein S18 |
|
affects expression |
EXP |
19 |
13,615,405 |
13,615,905 |
RGD:6480464 |
CTD |
| G |
RGD1561957 |
similar to ribosomal protein L21 |
|
affects expression |
EXP |
1 |
151,354,250 |
151,354,732 |
RGD:6480464 |
CTD |
| G |
RGD1561977 |
similar to DNA segment, Chr 5, ERATO Doi 577, expressed |
|
affects expression |
EXP |
14 |
15,969,610 |
15,972,242 |
RGD:6480464 |
CTD |
| G |
RGD1561984 |
similar to ribosomal protein L27a |
|
affects expression |
EXP |
8 |
54,204,346 |
54,204,792 |
RGD:6480464 |
CTD |
| G |
RGD1561993 |
similar to Small nuclear ribonucleoprotein F (snRNP-F) |
|
affects expression |
EXP |
3 |
157,509,205 |
157,510,508 |
RGD:6480464 |
CTD |
| G |
RGD1562014 |
similar to TDPOZ2 |
|
affects expression |
EXP |
2 |
188,806,752 |
188,807,846 |
RGD:6480464 |
CTD |
| G |
RGD1562019 |
similar to hypothetical protein 4930474N05 |
|
affects expression |
EXP |
18 |
42,156,442 |
42,158,075 |
RGD:6480464 |
CTD |
| G |
RGD1562058 |
similar to double homeobox, 4 |
|
affects expression |
EXP |
20 |
38,376,909 |
38,377,464 |
RGD:6480464 |
CTD |
| G |
RGD1562205 |
similar to serine/threonine kinase |
|
affects expression |
EXP |
17 |
67,494,566 |
67,530,122 |
RGD:6480464 |
CTD |
| G |
RGD1562266 |
similar to Hmgb1 protein |
|
affects expression |
EXP |
18 |
39,417,311 |
39,417,961 |
RGD:6480464 |
CTD |
| G |
RGD1562282 |
similar to Keratin-associated protein 5-4 (Ultrahigh sulfur keratin-associated protein 5.4) |
|
affects expression |
EXP |
8 |
120,953,381 |
120,953,827 |
RGD:6480464 |
CTD |
| G |
RGD1562320 |
similar to C-type lectin superfamily 4, member G |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
RGD1562376 |
similar to chromosome 6 open reading frame 70 |
|
affects expression |
EXP |
1 |
53,905,895 |
53,925,656 |
RGD:6480464 |
CTD |
| G |
RGD1562394 |
similar to ribosomal protein L30 |
|
affects expression |
EXP |
14 |
21,908,076 |
21,908,417 |
RGD:6480464 |
CTD |
| G |
RGD1562467 |
similar to hypothetical protein 4930509O22 |
|
affects expression |
EXP |
7 |
17,079,482 |
17,092,730 |
RGD:6480464 |
CTD |
| G |
RGD1562484 |
similar to mitochondrial ATP synthase coupling factor 6 |
|
affects expression |
EXP |
5 |
151,518,449 |
151,519,036 |
RGD:6480464 |
CTD |
| G |
RGD1562545 |
similar to TDPOZ2 |
|
affects expression |
EXP |
2 |
187,804,212 |
187,805,306 |
RGD:6480464 |
CTD |
| G |
RGD1562546 |
similar to trophinin isoform 1 |
|
affects expression |
EXP |
19 |
20,199,649 |
20,202,212 |
RGD:6480464 |
CTD |
| G |
RGD1562618 |
similar to RIKEN cDNA 6030419C18 gene |
|
affects expression |
EXP |
8 |
62,297,849 |
62,308,113 |
RGD:6480464 |
CTD |
| G |
RGD1562624 |
similar to RIKEN cDNA 1700001F09 |
|
affects expression |
EXP |
15 |
5,157,712 |
5,158,881 |
RGD:6480464 |
CTD |
| G |
RGD1562638 |
similar to MAP/microtubule affinity-regulating kinase 3 |
|
affects expression |
EXP |
16 |
68,750,733 |
68,775,989 |
RGD:6480464 |
CTD |
| G |
RGD1562650 |
similar to interferon alpha 8/6 precursor; IFNa8/6 (B6) |
|
affects expression |
EXP |
5 |
108,242,898 |
108,243,452 |
RGD:6480464 |
CTD |
| G |
RGD1562667 |
similar to leukocyte mono-Ig-like receptor2 |
|
affects expression |
EXP |
10 |
104,986,719 |
104,990,056 |
RGD:6480464 |
CTD |
| G |
RGD1562670 |
similar to hypothetical protein MGC67567 |
|
affects expression |
EXP |
20 |
38,383,331 |
38,390,377 |
RGD:6480464 |
CTD |
| G |
RGD1562677 |
similar to putative protein kinase |
|
affects expression |
EXP |
1 |
51,446,949 |
51,451,385 |
RGD:6480464 |
CTD |
| G |
RGD1562707 |
similar to CG8201-PO, isoform O |
|
affects expression |
EXP |
17 |
97,081,538 |
97,088,158 |
RGD:6480464 |
CTD |
| G |
RGD1562714 |
similar to spermatogenesis associated glutamate (E)-rich protein 4b |
|
affects expression |
EXP |
8 |
42,161,107 |
42,165,583 |
RGD:6480464 |
CTD |
| G |
RGD1562739 |
similar to STELLA |
|
affects expression |
EXP |
7 |
95,612,161 |
95,612,637 |
RGD:6480464 |
CTD |
| G |
RGD1562877 |
RGD1562877 |
|
affects expression |
EXP |
19 |
14,804,589 |
14,808,890 |
RGD:6480464 |
CTD |
| G |
RGD1562893 |
similar to putative homeobox protein |
|
affects expression |
EXP |
20 |
38,225,613 |
38,226,450 |
RGD:6480464 |
CTD |
| G |
RGD1562919 |
similar to hypothetical protein MGC67567 |
|
affects expression |
EXP |
20 |
37,982,817 |
37,991,145 |
RGD:6480464 |
CTD |
| G |
RGD1562932 |
similar to DNA segment, Chr 5, ERATO Doi 577, expressed |
|
affects expression |
EXP |
14 |
15,515,370 |
15,518,006 |
RGD:6480464 |
CTD |
| G |
RGD1562989 |
similar to serine/threonine kinase |
|
affects expression |
EXP |
17 |
67,477,228 |
67,480,263 |
RGD:6480464 |
CTD |
| G |
RGD1563107 |
RGD1563107 |
|
affects expression |
EXP |
1 |
50,446,815 |
50,463,553 |
RGD:6480464 |
CTD |
| G |
RGD1565623 |
similar to Interferon alpha-1 precursor |
|
affects expression |
EXP |
5 |
108,345,703 |
108,346,257 |
RGD:6480464 |
CTD |
| G |
RGD1565684 |
similar to kallikrein 1 precursor |
|
affects expression |
EXP |
1 |
94,467,531 |
94,470,687 |
RGD:6480464 |
CTD |
| G |
RGD1565859 |
RGD1565859 |
|
affects expression |
EXP |
1 |
202,377,082 |
202,386,197 |
RGD:6480464 |
CTD |
| G |
RGD1565894 |
similar to ribosomal protein L31 |
|
affects expression |
EXP |
18 |
60,227,354 |
60,231,020 |
RGD:6480464 |
CTD |
| G |
RGD1565911 |
similar to interferon alpha 8/6 precursor; IFNa8/6 (B6) |
|
affects expression |
EXP |
5 |
108,271,859 |
108,272,413 |
RGD:6480464 |
CTD |
| G |
RGD1566002 |
similar to RIKEN cDNA 3110001N18 |
|
affects expression |
EXP |
10 |
92,101,127 |
92,101,495 |
RGD:6480464 |
CTD |
| G |
RGD1566008 |
similar to RIKEN cDNA 1700001F22 |
|
affects expression |
EXP |
X |
142,615,470 |
142,616,015 |
RGD:6480464 |
CTD |
| G |
RGD1566040 |
similar to MAP/microtubule affinity-regulating kinase 4 (MAP/microtubule affinity-regulating kinase like 1) |
|
affects expression |
EXP |
17 |
67,719,008 |
67,720,852 |
RGD:6480464 |
CTD |
| G |
RGD1566047 |
similar to MAP/microtubule affinity-regulating kinase 4 (MAP/microtubule affinity-regulating kinase like 1) |
|
affects expression |
EXP |
17 |
67,848,857 |
67,858,122 |
RGD:6480464 |
CTD |
| G |
RGD1566225 |
similar to RIKEN cDNA 1700001F22 |
|
affects expression |
EXP |
X |
136,700,302 |
136,700,847 |
RGD:6480464 |
CTD |
| G |
RGD1566239 |
similar to RIKEN cDNA 2810428I15 |
|
affects expression |
EXP |
16 |
19,428,804 |
19,431,276 |
RGD:6480464 |
CTD |
| G |
RGD1566251 |
similar to hypothetical protein 4930509O22 |
|
affects expression |
EXP |
7 |
17,436,435 |
17,452,062 |
RGD:6480464 |
CTD |
| G |
RGD1566281 |
similar to ribosomal protein L21 |
|
affects expression |
EXP |
15 |
105,875,666 |
105,876,016 |
RGD:6480464 |
CTD |
| G |
RGD1566292 |
similar to Chain A, Human Ubiquitin-Conjugating Enzyme Ubc9 |
|
affects expression |
EXP |
14 |
54,533,495 |
54,533,965 |
RGD:6480464 |
CTD |
| G |
RGD1566353 |
similar to hypothetical protein 4930474N05 |
|
affects expression |
EXP |
16 |
11,563,518 |
11,572,392 |
RGD:6480464 |
CTD |
| G |
Rgs16 |
regulator of G-protein signaling 16 |
|
affects expression |
EXP |
13 |
68,807,863 |
68,811,307 |
RGD:6480464 |
CTD |
| G |
Rgs2 |
regulator of G-protein signaling 2 |
|
affects expression |
EXP |
13 |
57,891,849 |
57,894,452 |
RGD:6480464 |
CTD |
| G |
Rgs5 |
regulator of G-protein signaling 5 |
|
affects expression |
EXP |
13 |
85,445,325 |
85,482,294 |
RGD:6480464 |
CTD |
| G |
Rhbdd2 |
rhomboid domain containing 2 |
|
affects expression |
EXP |
12 |
22,198,539 |
22,208,465 |
RGD:6480464 |
CTD |
| G |
Rhbg |
Rh family, B glycoprotein |
|
affects expression |
EXP |
2 |
180,320,787 |
180,333,050 |
RGD:6480464 |
CTD |
| G |
Rhob |
ras homolog family member B |
|
affects expression |
EXP |
6 |
32,052,333 |
32,054,507 |
RGD:6480464 |
CTD |
| G |
Riok2 |
RIO kinase 2 |
|
affects expression |
EXP |
1 |
55,897,247 |
55,913,533 |
RGD:6480464 |
CTD |
| G |
Rlim |
ring finger protein, LIM domain interacting |
|
affects expression |
EXP |
X |
91,969,453 |
91,985,349 |
RGD:6480464 |
CTD |
| G |
Rnf138 |
ring finger protein 138, E3 ubiquitin protein ligase |
|
affects expression |
EXP |
18 |
12,764,220 |
12,788,635 |
RGD:6480464 |
CTD |
| G |
Rnf146 |
ring finger protein 146 |
|
affects expression |
EXP |
1 |
29,255,138 |
29,265,731 |
RGD:6480464 |
CTD |
| G |
Rnf41 |
ring finger protein 41 |
|
affects expression |
EXP |
7 |
1,704,204 |
1,725,892 |
RGD:6480464 |
CTD |
| G |
Rngtt |
RNA guanylyltransferase and 5'-phosphatase |
|
affects expression |
EXP |
5 |
49,605,150 |
49,811,502 |
RGD:6480464 |
CTD |
| G |
Ror2 |
receptor tyrosine kinase-like orphan receptor 2 |
|
affects expression |
EXP |
17 |
17,735,999 |
17,917,032 |
RGD:6480464 |
CTD |
| G |
Rpl22l1 |
ribosomal protein L22 like 1 |
|
affects expression |
EXP |
2 |
116,168,790 |
116,170,726 |
RGD:6480464 |
CTD |
| G |
Rpl22l2 |
ribosomal protein L22-like 2 |
|
affects expression |
EXP |
3 |
117,384,474 |
117,384,842 |
RGD:6480464 |
CTD |
| G |
Rpl29-ps3 |
ribosomal protein L29, pseudogene 3 |
|
affects expression |
EXP |
17 |
77,746,873 |
77,747,340 |
RGD:6480464 |
CTD |
| G |
Rpp30 |
ribonuclease P/MRP subunit |
|
affects expression |
EXP |
1 |
240,286,366 |
240,309,222 |
RGD:6480464 |
CTD |
| G |
Rpp38 |
ribonuclease P/MRP 38 subunit |
|
affects expression |
EXP |
17 |
86,033,450 |
86,036,990 |
RGD:6480464 |
CTD |
| G |
Rps7 |
ribosomal protein S7 |
|
affects expression |
EXP |
6 |
46,511,961 |
46,516,825 |
RGD:6480464 |
CTD |
| G |
Rsph3 |
radial spoke 3 homolog (Chlamydomonas) |
|
affects expression |
EXP |
1 |
41,313,530 |
41,336,537 |
RGD:6480464 |
CTD |
| G |
RT1-Cl |
RT1 class Ib, locus Cl |
|
affects expression |
EXP |
20 |
2,116,560 |
2,134,175 |
RGD:6480464 |
CTD |
| G |
RT1-EC2 |
RT1 class Ib, locus EC2 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
RT1-M3-1 |
RT1 class Ib, locus M3, gene 1 |
|
affects expression |
EXP |
20 |
1,412,553 |
1,416,692 |
RGD:6480464 |
CTD |
| G |
RT1-S2 |
RT1 class Ib, locus S2 |
|
affects expression |
EXP |
20 |
2,794,349 |
2,795,770 |
RGD:6480464 |
CTD |
| G |
S100a13 |
S100 calcium binding protein A13 |
|
affects expression |
EXP |
2 |
182,790,173 |
182,796,668 |
RGD:6480464 |
CTD |
| G |
S100a4 |
S100 calcium-binding protein A4 |
|
affects expression |
EXP |
2 |
182,885,070 |
182,887,380 |
RGD:6480464 |
CTD |
| G |
S100a6 |
S100 calcium binding protein A6 |
|
affects expression |
EXP |
2 |
182,895,080 |
182,896,305 |
RGD:6480464 |
CTD |
| G |
Samd4a |
sterile alpha motif domain containing 4A |
|
affects expression |
EXP |
15 |
22,847,701 |
22,952,499 |
RGD:6480464 |
CTD |
| G |
Sbspon |
somatomedin B and thrombospondin, type 1 domain containing |
|
affects expression |
EXP |
5 |
2,516,220 |
2,547,152 |
RGD:6480464 |
CTD |
| G |
Scml4 |
sex comb on midleg-like 4 (Drosophila) |
|
affects expression |
EXP |
20 |
46,771,530 |
46,864,100 |
RGD:6480464 |
CTD |
| G |
Scn4b |
sodium channel, voltage-gated, type IV, beta |
|
affects expression |
EXP |
8 |
48,091,561 |
48,106,735 |
RGD:6480464 |
CTD |
| G |
Scnn1a |
sodium channel, nonvoltage-gated 1 alpha |
|
affects expression |
EXP |
4 |
161,445,936 |
161,469,267 |
RGD:6480464 |
CTD |
| G |
Scoc |
short coiled-coil protein |
|
affects expression |
EXP |
19 |
26,351,894 |
26,396,488 |
RGD:6480464 |
CTD |
| G |
Scpep1 |
serine carboxypeptidase 1 |
|
affects expression |
EXP |
10 |
77,347,473 |
77,377,945 |
RGD:6480464 |
CTD |
| G |
Scrn1 |
secernin 1 |
|
affects expression |
EXP |
4 |
82,912,923 |
82,971,950 |
RGD:6480464 |
CTD |
| G |
Sctr |
secretin receptor |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Sdr16c6 |
short chain dehydrogenase/reductase family 16C, member 6 |
|
affects expression |
EXP |
5 |
17,414,523 |
17,438,458 |
RGD:6480464 |
CTD |
| G |
Senp17 |
Sumo1/sentrin/SMT3 specific peptidase 17 |
|
affects expression |
EXP |
4 |
164,737,274 |
164,738,701 |
RGD:6480464 |
CTD |
| G |
Sept4 |
septin 4 |
|
affects expression |
EXP |
10 |
75,871,422 |
75,880,878 |
RGD:6480464 |
CTD |
| G |
Serpinb1a |
serine (or cysteine) proteinase inhibitor, clade B, member 1a |
|
affects expression |
EXP |
17 |
37,950,875 |
37,959,284 |
RGD:6480464 |
CTD |
| G |
Sesn2 |
sestrin 2 |
|
affects expression |
EXP |
5 |
152,639,951 |
152,655,828 |
RGD:6480464 |
CTD |
| G |
Sesn3 |
sestrin 3 |
|
affects expression |
EXP |
8 |
11,076,055 |
11,125,523 |
RGD:6480464 |
CTD |
| G |
Sez6 |
seizure related 6 homolog (mouse) |
|
affects expression |
EXP |
10 |
63,994,947 |
64,021,007 |
RGD:6480464 |
CTD |
| G |
Sfxn1 |
sideroflexin 1 |
|
affects expression |
EXP |
17 |
16,601,066 |
16,636,502 |
RGD:6480464 |
CTD |
| G |
Sh3bgrl3 |
SH3 domain binding glutamic acid-rich protein-like 3 |
|
affects expression |
EXP |
5 |
152,877,343 |
152,878,716 |
RGD:6480464 |
CTD |
| G |
Sik1 |
salt-inducible kinase 1 |
|
affects expression |
EXP |
20 |
10,282,203 |
10,291,735 |
RGD:6480464 |
CTD |
| G |
Sla2 |
Src-like-adaptor 2 |
|
affects expression |
EXP |
3 |
147,277,668 |
147,290,729 |
RGD:6480464 |
CTD |
| G |
Slc13a3 |
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 |
|
affects expression |
EXP |
3 |
156,447,900 |
156,510,620 |
RGD:6480464 |
CTD |
| G |
Slc15a3 |
solute carrier family 15, member 3 |
|
affects expression |
EXP |
1 |
213,341,322 |
213,356,103 |
RGD:6480464 |
CTD |
| G |
Slc16a1 |
solute carrier family 16, member 1 (monocarboxylic acid transporter 1) |
|
affects expression |
EXP |
2 |
199,860,341 |
199,879,856 |
RGD:6480464 |
CTD |
| G |
Slc16a2 |
solute carrier family 16, member 2 (thyroid hormone transporter) |
|
affects expression |
EXP |
X |
91,700,554 |
91,825,108 |
RGD:6480464 |
CTD |
| G |
Slc1a2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
|
affects expression |
EXP |
3 |
87,870,558 |
87,992,401 |
RGD:6480464 |
CTD |
| G |
Slc1a4 |
solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 |
|
affects expression |
EXP |
14 |
101,123,740 |
101,153,790 |
RGD:6480464 |
CTD |
| G |
Slc20a1 |
solute carrier family 20 (phosphate transporter), member 1 |
|
affects expression |
EXP |
3 |
116,813,990 |
116,828,049 |
RGD:6480464 |
CTD |
| G |
Slc25a25 |
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25 |
|
affects expression |
EXP |
3 |
11,539,415 |
11,549,538 |
RGD:6480464 |
CTD |
| G |
Slc25a29 |
solute carrier family 25 (mitochondrial carnitine/acylcarnitine carrier), member 29 |
|
affects expression |
EXP |
6 |
133,166,812 |
133,177,600 |
RGD:6480464 |
CTD |
| G |
Slc25a35 |
solute carrier family 25, member 35 |
|
affects expression |
EXP |
10 |
55,727,383 |
55,731,377 |
RGD:6480464 |
CTD |
| G |
Slc25a47 |
solute carrier family 25, member 47 |
|
affects expression |
EXP |
6 |
133,192,144 |
133,197,778 |
RGD:6480464 |
CTD |
| G |
Slc28a2 |
solute carrier family 28 (sodium-coupled nucleoside transporter), member 2 |
|
affects expression |
EXP |
3 |
109,350,531 |
109,372,027 |
RGD:6480464 |
CTD |
| G |
Slc34a2 |
solute carrier family 34 (sodium phosphate), member 2 |
|
affects expression |
EXP |
14 |
62,660,006 |
62,679,311 |
RGD:6480464 |
CTD |
| G |
Slc35b3 |
solute carrier family 35, member B3 |
|
affects expression |
EXP |
17 |
31,910,886 |
31,938,409 |
RGD:6480464 |
CTD |
| G |
Slc35g1 |
solute carrier family 35, member G1 |
|
affects expression |
EXP |
1 |
242,713,535 |
242,719,969 |
RGD:6480464 |
CTD |
| G |
Slc39a11 |
solute carrier family 39 (metal ion transporter), member 11 |
|
affects expression |
EXP |
10 |
102,863,399 |
103,189,081 |
RGD:6480464 |
CTD |
| G |
Slc39a4 |
solute carrier family 39 (zinc transporter), member 4 |
|
affects expression |
EXP |
7 |
114,661,925 |
114,666,098 |
RGD:6480464 |
CTD |
| G |
Slc44a4 |
solute carrier family 44, member 4 |
|
affects expression |
EXP |
20 |
4,005,154 |
4,021,270 |
RGD:6480464 |
CTD |
| G |
Slc45a3 |
solute carrier family 45, member 3 |
|
affects expression |
EXP |
13 |
44,840,555 |
44,861,173 |
RGD:6480464 |
CTD |
| G |
Slc51b |
solute carrier family 51, beta subunit |
|
affects expression |
EXP |
8 |
69,661,815 |
69,669,889 |
RGD:6480464 |
CTD |
| G |
Slc5a9 |
solute carrier family 5 (sodium/glucose cotransporter), member 9 |
|
affects expression |
EXP |
5 |
133,455,811 |
133,465,217 |
RGD:6480464 |
CTD |
| G |
Slc6a6 |
solute carrier family 6 (neurotransmitter transporter, taurine), member 6 |
|
affects expression |
EXP |
4 |
125,875,817 |
125,945,795 |
RGD:6480464 |
CTD |
| G |
Smyd5 |
SMYD family member 5 |
|
affects expression |
EXP |
4 |
119,686,587 |
119,701,588 |
RGD:6480464 |
CTD |
| G |
Snrnp27 |
small nuclear ribonucleoprotein 27 (U4/U6.U5) |
|
affects expression |
EXP |
4 |
120,828,680 |
120,838,238 |
RGD:6480464 |
CTD |
| G |
Snrpc |
small nuclear ribonucleoprotein polypeptide C |
|
affects expression |
EXP |
20 |
6,045,678 |
6,063,842 |
RGD:6480464 |
CTD |
| G |
Snrpn |
small nuclear ribonucleoprotein polypeptide N |
|
affects expression |
EXP |
1 |
111,570,605 |
111,592,659 |
RGD:6480464 |
CTD |
| G |
Snw1 |
SNW domain containing 1 |
|
affects expression |
EXP |
6 |
111,688,742 |
111,712,826 |
RGD:6480464 |
CTD |
| G |
Snx10 |
sorting nexin 10 |
|
affects expression |
EXP |
4 |
79,789,556 |
79,853,215 |
RGD:6480464 |
CTD |
| G |
Sort1 |
sortilin 1 |
|
affects expression |
EXP |
2 |
203,853,009 |
203,931,559 |
RGD:6480464 |
CTD |
| G |
Sp1 |
Sp1 transcription factor |
|
multiple interactions |
ISO |
7 |
141,164,180 |
141,194,509 |
RGD:6480464 |
CTD |
| G |
Sp1 |
Sp1 transcription factor |
|
decreases activity |
ISO |
7 |
141,164,180 |
141,194,509 |
RGD:6480464 |
CTD |
| G |
Sparcl1 |
SPARC-like 1 (hevin) |
|
affects expression |
EXP |
14 |
6,766,347 |
6,797,581 |
RGD:6480464 |
CTD |
| G |
Spata24 |
spermatogenesis associated 24 |
|
affects expression |
EXP |
18 |
28,279,137 |
28,281,228 |
RGD:6480464 |
CTD |
| G |
Spata5 |
spermatogenesis associated 5 |
|
affects expression |
EXP |
2 |
123,962,875 |
124,154,127 |
RGD:6480464 |
CTD |
| G |
Spata7 |
spermatogenesis associated 7 |
|
affects expression |
EXP |
6 |
122,786,739 |
122,832,181 |
RGD:6480464 |
CTD |
| G |
Spetex-2A |
Spetex-2A protein |
|
affects expression |
EXP |
15 |
6,011,172 |
6,014,760 |
RGD:6480464 |
CTD |
| G |
Spetex-2B |
Spetex-2B protein |
|
affects expression |
EXP |
15 |
6,011,208 |
6,014,735 |
RGD:6480464 |
CTD |
| G |
Spetex-2C |
Spetex-2C protein |
|
affects expression |
EXP |
15 |
5,435,691 |
5,439,580 |
RGD:6480464 |
CTD |
| G |
Spetex-2D |
Spetex-2D protein |
|
affects expression |
EXP |
15 |
5,922,760 |
5,925,028 |
RGD:6480464 |
CTD |
| G |
Spetex-2E |
Spetex-2E protein |
|
affects expression |
EXP |
15 |
6,289,492 |
6,292,666 |
RGD:6480464 |
CTD |
| G |
Spetex-2F |
Spetex-2F protein |
|
affects expression |
EXP |
15 |
5,295,362 |
5,298,510 |
RGD:6480464 |
CTD |
| G |
Spetex-2G |
Spetex-2G protein |
|
affects expression |
EXP |
15 |
5,547,324 |
5,550,592 |
RGD:6480464 |
CTD |
| G |
Spetex-2H |
Spetex-2H protein |
|
affects expression |
EXP |
15 |
5,180,002 |
5,186,910 |
RGD:6480464 |
CTD |
| G |
Spink1 |
serine peptidase inhibitor, Kazal type 1 |
|
affects expression |
EXP |
18 |
37,090,934 |
37,099,835 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Sprr1a |
small proline-rich protein 1A |
|
affects expression |
EXP |
2 |
185,463,951 |
185,465,849 |
RGD:6480464 |
CTD |
| G |
Srcap |
Snf2-related CREBBP activator protein |
|
affects expression |
EXP |
1 |
186,800,822 |
186,846,135 |
RGD:6480464 |
CTD |
| G |
Srd5a1 |
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) |
|
affects expression |
EXP |
17 |
3,845,190 |
3,879,165 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
affects expression |
EXP |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srfbp1 |
serum response factor binding protein 1 |
|
affects expression |
EXP |
18 |
47,849,873 |
47,870,957 |
RGD:6480464 |
CTD |
| G |
Sry |
sex determining region Y |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ssc5d |
scavenger receptor cysteine rich domain containing (5 domains) |
|
affects expression |
EXP |
1 |
67,630,584 |
67,648,373 |
RGD:6480464 |
CTD |
| G |
St14 |
suppression of tumorigenicity 14 (colon carcinoma) |
|
affects expression |
EXP |
8 |
30,916,769 |
30,932,214 |
RGD:6480464 |
CTD |
| G |
Stac3 |
SH3 and cysteine rich domain 3 |
|
affects expression |
EXP |
7 |
67,478,506 |
67,485,909 |
RGD:6480464 |
CTD |
| G |
Stard3nl |
STARD3 N-terminal like |
|
affects expression |
EXP |
17 |
53,402,078 |
53,436,085 |
RGD:6480464 |
CTD |
| G |
Stmn1 |
stathmin 1 |
|
affects expression |
EXP |
5 |
153,226,420 |
153,232,084 |
RGD:6480464 |
CTD |
| G |
Stx6 |
syntaxin 6 |
|
affects expression |
EXP |
13 |
70,121,864 |
70,169,379 |
RGD:6480464 |
CTD |
| G |
Stx7 |
syntaxin 7 |
|
affects expression |
EXP |
1 |
21,721,897 |
21,762,024 |
RGD:6480464 |
CTD |
| G |
Tango2 |
transport and golgi organization 2 homolog (Drosophila) |
|
affects expression |
EXP |
11 |
84,643,644 |
84,686,639 |
RGD:6480464 |
CTD |
| G |
Tenm2 |
teneurin transmembrane protein 2 |
|
affects expression |
EXP |
10 |
20,939,207 |
21,888,443 |
RGD:6480464 |
CTD |
| G |
Tff1 |
trefoil factor 1 |
|
decreases expression |
ISO |
20 |
9,526,674 |
9,530,534 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
multiple interactions |
ISO |
13 |
102,718,703 |
102,818,768 |
RGD:6480464 |
CTD |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
increases expression |
ISO |
13 |
102,718,703 |
102,818,768 |
RGD:6480464 |
CTD |
| G |
Tgfb3 |
transforming growth factor, beta 3 |
|
increases expression |
ISO |
6 |
110,173,443 |
110,195,215 |
RGD:6480464 |
CTD |
| G |
Tgfb3 |
transforming growth factor, beta 3 |
|
multiple interactions |
ISO |
6 |
110,173,443 |
110,195,215 |
RGD:6480464 |
CTD |
| G |
Them6 |
thioesterase superfamily member 6 |
|
affects expression |
EXP |
7 |
112,835,301 |
112,838,479 |
RGD:6480464 |
CTD |
| G |
Tma16 |
translation machinery associated 16 homolog (S. cerevisiae) |
|
affects expression |
EXP |
16 |
24,948,510 |
24,964,415 |
RGD:6480464 |
CTD |
| G |
Tmem251 |
transmembrane protein 251 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfaip8 |
tumor necrosis factor, alpha-induced protein 8 |
|
affects expression |
EXP |
18 |
45,083,452 |
45,126,709 |
RGD:6480464 |
CTD |
| G |
Tnfrsf12a |
tumor necrosis factor receptor superfamily, member 12a |
|
affects expression |
EXP |
10 |
12,940,334 |
12,942,343 |
RGD:6480464 |
CTD |
| G |
Tnfrsf19 |
tumor necrosis factor receptor superfamily, member 19 |
|
affects expression |
EXP |
15 |
40,051,695 |
40,117,968 |
RGD:6480464 |
CTD |
| G |
Tnnc1 |
troponin C type 1 (slow) |
|
affects expression |
EXP |
16 |
6,639,357 |
6,642,331 |
RGD:6480464 |
CTD |
| G |
Tns3 |
tensin 3 |
|
affects expression |
EXP |
14 |
88,999,003 |
89,182,348 |
RGD:6480464 |
CTD |
| G |
Tomm5 |
translocase of outer mitochondrial membrane 5 homolog (yeast) |
|
affects expression |
EXP |
5 |
61,665,299 |
61,668,124 |
RGD:6480464 |
CTD |
| G |
Tor3a |
torsin family 3, member A |
|
affects expression |
EXP |
13 |
71,849,603 |
71,874,034 |
RGD:6480464 |
CTD |
| G |
Tpm1 |
tropomyosin 1, alpha |
|
affects expression |
EXP |
8 |
71,331,304 |
71,358,063 |
RGD:6480464 |
CTD |
| G |
Traf3ip2 |
Traf3 interacting protein 2 |
|
affects expression |
EXP |
20 |
43,747,622 |
43,792,255 |
RGD:6480464 |
CTD |
| G |
Trappc2 |
trafficking protein particle complex 2 |
|
affects expression |
EXP |
X |
48,690,381 |
48,701,588 |
RGD:6480464 |
CTD |
| G |
Trib3 |
tribbles homolog 3 (Drosophila) |
|
affects expression |
EXP |
3 |
142,664,641 |
142,670,135 |
RGD:6480464 |
CTD |
| G |
Trim37 |
tripartite motif-containing 37 |
|
affects expression |
EXP |
10 |
75,404,911 |
75,537,072 |
RGD:6480464 |
CTD |
| G |
Trmt6 |
tRNA methyltransferase 6 homolog (S. cerevisiae) |
|
affects expression |
EXP |
3 |
120,602,570 |
120,614,291 |
RGD:6480464 |
CTD |
| G |
Trpm4 |
transient receptor potential cation channel, subfamily M, member 4 |
|
affects expression |
EXP |
1 |
95,773,485 |
95,803,542 |
RGD:6480464 |
CTD |
| G |
Tsen2 |
tRNA splicing endonuclease 2 homolog (S. cerevisiae) |
|
affects expression |
EXP |
4 |
151,672,953 |
151,708,835 |
RGD:6480464 |
CTD |
| G |
Tspan8 |
tetraspanin 8 |
|
affects expression |
EXP |
7 |
55,104,257 |
55,136,906 |
RGD:6480464 |
CTD |
| G |
Tsx |
testis specific X-linked gene |
|
affects expression |
EXP |
X |
91,398,417 |
91,408,922 |
RGD:6480464 |
CTD |
| G |
Ttc23 |
tetratricopeptide repeat domain 23 |
|
affects expression |
EXP |
1 |
122,395,433 |
122,469,865 |
RGD:6480464 |
CTD |
| G |
Ttc39a |
tetratricopeptide repeat domain 39A |
|
affects expression |
EXP |
5 |
130,761,328 |
130,800,627 |
RGD:6480464 |
CTD |
| G |
Ttc39b |
tetratricopeptide repeat domain 39B |
|
affects expression |
EXP |
5 |
102,064,300 |
102,162,978 |
RGD:6480464 |
CTD |
| G |
Tube1 |
tubulin, epsilon 1 |
|
affects expression |
EXP |
20 |
43,280,097 |
43,298,415 |
RGD:6480464 |
CTD |
| G |
Tusc3 |
tumor suppressor candidate 3 |
|
affects expression |
EXP |
16 |
56,760,904 |
56,929,685 |
RGD:6480464 |
CTD |
| G |
Twistnb |
TWIST neighbor |
|
affects expression |
EXP |
6 |
51,789,847 |
51,807,076 |
RGD:6480464 |
CTD |
| G |
Ubd |
ubiquitin D |
|
affects expression |
EXP |
20 |
1,475,944 |
1,477,895 |
RGD:6480464 |
CTD |
| G |
Ufm1 |
ubiquitin-fold modifier 1 |
|
affects expression |
EXP |
2 |
143,057,364 |
143,064,329 |
RGD:6480464 |
CTD |
| G |
Ugt1a2 |
UDP glucuronosyltransferase 1 family, polypeptide A2 |
|
affects expression |
EXP |
9 |
87,081,132 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a6 |
UDP glucuronosyltransferase 1 family, polypeptide A6 |
|
affects expression |
EXP |
9 |
87,037,154 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a7c |
UDP glucuronosyltransferase 1 family, polypeptide A7C |
|
affects expression |
EXP |
9 |
87,029,500 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt2b |
UDP glycosyltransferase 2 family, polypeptide B |
|
affects expression |
EXP |
14 |
22,154,370 |
22,178,222 |
RGD:6480464 |
CTD |
| G |
Ugt2b17 |
UDP glucuronosyltransferase 2 family, polypeptide B17 |
|
affects expression |
EXP |
14 |
22,639,182 |
22,650,931 |
RGD:6480464 |
CTD |
| G |
Unc13d |
unc-13 homolog D (C. elegans) |
|
affects expression |
EXP |
10 |
106,170,475 |
106,185,215 |
RGD:6480464 |
CTD |
| G |
Unc5b |
unc-5 homolog B (C. elegans) |
|
affects expression |
EXP |
20 |
28,095,243 |
28,162,204 |
RGD:6480464 |
CTD |
| G |
Upp2 |
uridine phosphorylase 2 |
|
affects expression |
EXP |
3 |
40,492,002 |
40,536,956 |
RGD:6480464 |
CTD |
| G |
Ush1g |
Usher syndrome 1G |
|
affects expression |
EXP |
10 |
105,395,184 |
105,399,053 |
RGD:6480464 |
CTD |
| G |
Usp11 |
ubiquitin specific peptidase 11 |
|
affects expression |
EXP |
X |
12,890,515 |
12,906,686 |
RGD:6480464 |
CTD |
| G |
UST4r |
integral membrane transport protein UST4r |
|
affects expression |
EXP |
1 |
210,618,706 |
210,688,125 |
RGD:6480464 |
CTD |
| G |
V1ra14 |
vomeronasal 1 receptor A14 |
|
affects expression |
EXP |
4 |
124,818,345 |
124,819,364 |
RGD:6480464 |
CTD |
| G |
Vim |
vimentin |
|
decreases expression |
ISO |
17 |
87,847,280 |
87,855,763 |
RGD:6480464 |
CTD |
| G |
Vkorc1l1 |
vitamin K epoxide reductase complex, subunit 1-like 1 |
|
affects expression |
EXP |
12 |
27,764,873 |
27,813,093 |
RGD:6480464 |
CTD |
| G |
Vnn1 |
vanin 1 |
|
affects expression |
EXP |
1 |
22,087,290 |
22,097,592 |
RGD:6480464 |
CTD |
| G |
Vom2r1 |
vomeronasal 2 receptor, 1 |
|
affects expression |
EXP |
1 |
245,888 |
267,011 |
RGD:6480464 |
CTD |
| G |
Vom2r2 |
vomeronasal 2 receptor, 2 |
|
affects expression |
EXP |
1 |
760,658 |
765,914 |
RGD:6480464 |
CTD |
| G |
Vom2r6 |
vomeronasal 2 receptor, 6 |
|
affects expression |
EXP |
1 |
1,287,086 |
1,295,756 |
RGD:6480464 |
CTD |
| G |
Vom2r63 |
vomeronasal 2 receptor, 63 |
|
affects expression |
EXP |
12 |
18,210,310 |
18,239,240 |
RGD:6480464 |
CTD |
| G |
Vom2r65 |
vomeronasal 2 receptor, 65 |
|
affects expression |
EXP |
14 |
44,953 |
57,338 |
RGD:6480464 |
CTD |
| G |
Vps37a |
vacuolar protein sorting 37 homolog A (S. cerevisiae) |
|
affects expression |
EXP |
16 |
55,077,793 |
55,118,155 |
RGD:6480464 |
CTD |
| G |
Vrk2 |
vaccinia related kinase 2 |
|
affects expression |
EXP |
14 |
107,287,844 |
107,450,960 |
RGD:6480464 |
CTD |
| G |
Vwde |
von Willebrand factor D and EGF domains |
|
affects expression |
EXP |
4 |
38,625,182 |
38,704,716 |
RGD:6480464 |
CTD |
| G |
Vwf |
von Willebrand factor |
|
affects expression |
EXP |
4 |
161,723,415 |
161,854,766 |
RGD:6480464 |
CTD |
| G |
Wbp5 |
WW domain binding protein 5 |
|
affects expression |
EXP |
X |
123,554,560 |
123,556,844 |
RGD:6480464 |
CTD |
| G |
Wdr35 |
WD repeat domain 35 |
|
affects expression |
EXP |
6 |
32,522,578 |
32,523,842 |
RGD:6480464 |
CTD |
| G |
Wdr60 |
WD repeat domain 60 |
|
affects expression |
EXP |
6 |
143,478,863 |
143,534,960 |
RGD:6480464 |
CTD |
| G |
Wdr67 |
WD repeat domain 67 |
|
affects expression |
EXP |
7 |
94,615,000 |
94,676,965 |
RGD:6480464 |
CTD |
| G |
Wdr73 |
WD repeat domain 73 |
|
affects expression |
EXP |
1 |
137,088,347 |
137,096,492 |
RGD:6480464 |
CTD |
| G |
Wnt3a |
wingless-type MMTV integration site family, member 3A |
|
affects expression |
EXP |
10 |
45,553,682 |
45,594,983 |
RGD:6480464 |
CTD |
| G |
Wnt4 |
wingless-type MMTV integration site family, member 4 |
|
affects expression |
EXP |
5 |
156,064,371 |
156,083,198 |
RGD:6480464 |
CTD |
| G |
Wwox |
WW domain-containing oxidoreductase |
|
affects expression |
EXP |
19 |
44,516,391 |
44,829,849 |
RGD:6480464 |
CTD |
| G |
Xiap |
X-linked inhibitor of apoptosis |
|
decreases expression |
ISO |
X |
3,011,520 |
3,047,798 |
RGD:6480464 |
CTD |
| G |
Xiap |
X-linked inhibitor of apoptosis |
|
multiple interactions |
ISO |
X |
3,011,520 |
3,047,798 |
RGD:6480464 |
CTD |
| G |
Xpa |
xeroderma pigmentosum, complementation group A |
|
affects expression |
EXP |
5 |
62,706,719 |
62,750,771 |
RGD:6480464 |
CTD |
| G |
Xpr1 |
xenotropic and polytropic retrovirus receptor 1 |
|
affects expression |
EXP |
13 |
70,238,356 |
70,379,254 |
RGD:6480464 |
CTD |
| G |
Zbtb40 |
zinc finger and BTB domain containing 40 |
|
affects expression |
EXP |
5 |
155,748,784 |
155,813,330 |
RGD:6480464 |
CTD |
| G |
Zbtb41 |
zinc finger and BTB domain containing 41 |
|
affects expression |
EXP |
13 |
52,778,992 |
52,802,582 |
RGD:6480464 |
CTD |
| G |
Zbtb8os |
zinc finger and BTB domain containing 8 opposite strand |
|
affects expression |
EXP |
5 |
148,492,643 |
148,504,132 |
RGD:6480464 |
CTD |
| G |
Zdhhc2 |
zinc finger, DHHC-type containing 2 |
|
affects expression |
EXP |
16 |
55,155,221 |
55,225,216 |
RGD:6480464 |
CTD |
| G |
Zeb2 |
zinc finger E-box binding homeobox 2 |
|
affects expression |
EXP |
3 |
25,513,009 |
25,654,964 |
RGD:6480464 |
CTD |
| G |
Zfand2a |
zinc finger, AN1-type domain 2A |
|
affects expression |
EXP |
12 |
15,661,609 |
15,672,672 |
RGD:6480464 |
CTD |
| G |
Zfhx4 |
zinc finger homeobox 4 |
|
affects expression |
EXP |
2 |
98,549,509 |
98,734,901 |
RGD:6480464 |
CTD |
| G |
Zfp191 |
zinc finger protein 191 |
|
affects expression |
EXP |
18 |
15,782,909 |
15,790,125 |
RGD:6480464 |
CTD |
| G |
Zfp362 |
zinc finger protein 362 |
|
affects expression |
EXP |
5 |
148,000,281 |
148,022,124 |
RGD:6480464 |
CTD |
| G |
Zfp386 |
zinc finger protein 386 (Kruppel-like) |
|
affects expression |
EXP |
6 |
143,311,722 |
143,326,401 |
RGD:6480464 |
CTD |
| G |
Zfp52 |
zinc finger protein 52 |
|
affects expression |
EXP |
1 |
59,540,774 |
59,568,607 |
RGD:6480464 |
CTD |
| G |
Zfp639 |
zinc finger protein 639 |
|
affects expression |
EXP |
2 |
118,718,400 |
118,725,490 |
RGD:6480464 |
CTD |
| G |
Zfyve9 |
zinc finger, FYVE domain containing 9 |
|
affects expression |
EXP |
5 |
129,924,320 |
130,083,310 |
RGD:6480464 |
CTD |
| G |
Zmynd12 |
zinc finger, MYND-type containing 12 |
|
affects expression |
EXP |
5 |
140,012,776 |
140,046,983 |
RGD:6480464 |
CTD |
Term paths to the root
|